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ABBREVIATION: 
 
AKI   – Acute Kidney Injury  
IMCU – Intensive Medical Care Unit  
BP   – Blood Pressure  
PR  – Pulse Rate  
HR   – Haemorrhagin 
DIC   – Disseminated Intravascular Coagulation  
MAHA  – Micro AngiopathicHaemolyticAnaemia 
RVV   – Russells’ Viper Venom  
ARF   – Acute Renal Failure  
CaCl2  – Calcium Chloride  
CPK  –CreatininePhospho Kinase  
CK  – Congested Kidney  
ABG  – Arterial Blood Gas  
ASV    – Anti Snake Venom  
AV block – Atrio Ventricular Block  
DNA   – DeoxyRibo Nucleic Acid  
WBCT  – Whole Blood Clotting Time  
FDP  – Fibrin Degradation Product  
ATN  – Acute Tubular Necrosis  
ACN   – Acute Cortical Necrosis 
RBC –Red blood cells 
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ABSTRACT 
BACKGROUND: 
 Snake bite is one of the most preventable causes of deaths and the 
incidence of snake bite is on increasing trend due to various factors. The 
most serious complication of snake bite is AKI and my study is to assess 
thrombocytopenia and albuminuria as early predictors of AKI in snake 
bite. 
METHODOLOGY: 
                             Fifty patients who got admitted in Thanjavur Medical 
College for the period of six months from March 2017 to August 2017 with 
history of snake bite were taken for study and they were followed with 
blood urea, serum creatinine urine albumin and platelet count and assess 
which subset of patients were progressing to AKI and how the detection of 
albuminuria and thrombocytopenia helps in assessment of progression of 
cases to AKI. 
CONCLUSIONS: 
 In patients with snake bite ,Albuminuria and 
thrombocytopenia are associated with development of Acute kidney injury 
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1.    INTRODUCTION 
  Snakes are a fascinating part of nature. Their colour movement and 
secret habits make them more mysterious. India is home to some of the most 
poisonous snakes in the earth, most of which are located in rural areas. 
Venomous snakebites are an important medical problem and occupational 
hazard in India. Russell's viper is the major cause of snakebite leading to 
increased morbidity and mortality following acute kidney injury AKI 
(32)
. The 
annual mortality is around 30,000 most of them from South-East Asia and West 
Africa.  
Approximately, 10,000 deaths occur in India. An incidence of renal 
involvement with snakebite envenomation of 1.4-28% has been reported in 
various series,] and incidence of ARF is 10-32%. Among multifactorial cause 
for the pathogenesis of snakebite-induced AKI
(33,63,64,65,66)
 (SAKI), elevated 
oxidative, and carbonyl stress (CS) leading cause of kidney injury.  Oxidative 
stress (OS) results in the modification of protein either directly through the 
oxidation of amino acid residues by reactive oxygen species (ROS) or indirectly 
by an increased generation of reactive carbonyl species. 
Although increased CS and protein modification has been extensively 
studied in both hyperglycaemic and corticotropin-releasing factor and many 
cases of AKI
(35)
, proteins damage due to OS and CS in SAKI has not been 
described well in literature. 
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Snake bites cause substantial mortality and morbidity in India. Most of the 
snake bites occur when people are working in bare footed conditions, in the 
fields or while walking in the night or in the morning along fields and along 
roads.Superstitions, wrong practises, misconceptions, handicap doctors who 
care primary attention. 
      Out of the 3000 species of snakes in the world, 216 species of snakes are 
found in India and in them 52 species of snakes are poisonous. Our venomous 
species belong to major families. They are Elapidae and Viperidae. 
We observe acute renal failure/acute kidney injury
(41)
 in most of the cases. The 
gravity, spectrum and outcome varies. Our study is to observe that how many 
cases with thrombocytopenia and albuminuria progress to acute renal failure/ 
acute kidney injury
(42)
. 
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2.  AIMS OF STUDY 
 
1. To correlate the association of albuminuria on presentation and acute 
kidney injury. 
 
2.  To correlate the association of thrombocytopenia  on presentation and 
acute kidney injury. 
 
3. To follow up the cases after they progress to acute kidney injury. 
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3. REVIEW OF LITERATURE 
3.1 EPIDEMIOLOGY OF VENOMOUS SNAKES AND SNAKE BITE 
INDUCED ACUTE KIDNEY INJURY 
           Snake bite is a preventable health hazard in the tropical regions. Very 
large scale research is going on due to its high incidence in those areas. It 
accounts for 125-175 deaths per day in India and the annual deaths per year are 
around 45000. It is the cause for a major preventable death. In India, the highest 
incidence is in Tamilnadu,Kerala, west Bengal, Uttar Pradesh and Maharashtra. 
Snakebites are reported from virtually every part of the world, except 
those countries where snakes (especially venomous snakes) are relatively rare. 
The incidence of serious bites is signiﬁcantly higher in the tropics than in 
industrialised nations of the West.  
This is exempliﬁed by the fact that while the USA records 6,000 to 8,000 
venomous bites per year, with mortality ranging from 5 to 15 deaths, India 
records about 200,000 bites, of which nearly 15,000 end in death. In Britain, 
hardly 200 bites are reported each year, and only 14 deaths have occurred in the 
last 100 years! Epidemics of snakebite have resulted from a sudden increase in 
snake population density, for example after ﬂooding in Columbia, Pakistan, 
India, and Bangladesh.  
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Invasion of the snake’s habitat by large numbers of people may also be 
followed by an increased incidence of snakebite. This occurred during the 
construction of new roads through jungles in South America, and during the 
movement of farmers to newly immigrated areas in the former dry zone of Sri 
Lanka. Among the various states in India, Maharashtra records a high incidence 
of snakebites—more than 1,000 bites per year. Most of the bites are reported 
from rural parts of the state.  
Other states with signiﬁcant reportage of snakebites include West Bengal, 
Uttar  Pradesh, Tamil Nadu, and Kerala. Most of the bites are said to be due to 
saw-scaled viper (almost two-thirds), while one-fourth of the number is due to 
Russell’s viper; cobra, krait, pit viper, etc., account for only a small number of 
cases. A recent report from South India indicates that nearly 20% of poisoning 
cases admitted to hospitals could be due to envenomations. 
Snake bites happen to farmers when the farmers work in field bare footed 
unintentionally in a handful of foliage rolling over the snake while asleep , 
while working in plantation and in those who handle snakes. Males are affected 
more than females and the lower limbs are the most common sites.      
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3.2 VENOMOUS SNAKES BELONG TO 5 FAMILIES
(46,47)
: 
 1. Colubridae:  
This family includes almost 1400 species, or 75% of all the snake genera 
and 78% of all the snake species in the world. Approximately 400 of these 
species of Colubridae have short immobile fangs, or enlarged solid teeth at the 
posterior end of the maxilla. About one third of the Colubrid species possess 
rear fangs which deliver toxic saliva delivered by a chewing motion. Colubrid 
snakes
 
 are the predominant species on all continents except Australia. 
Examples include mountain racer, Western and Eastern hognose snakes, parrot 
snake, rat snake, wandering garter snake, etc.  
2. Atractaspididae:  
This family comprises African and Middle Eastern burrowing asps or 
stilleto snakes (also known as burrowing or mole vipers or adders, false vipers, 
side-stabbing snakes), which have very long front fangs used for immobilising 
their prey by a side-swiping motion. These fangs often protrude from the corner 
of the partially closed mouth.  
3.Elapidae:  
These snakes have relatively short, ﬁxed front (proteroglyph) fangs, 
which however may extend up to 10 mm long). They are anchored at the 
anterior portion of the maxilla. Examples include the following— a. Cobras 
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(Naja) b. Kraits (Bungarus) c. Coral snakes (Calliophis, Maticora, Micrurus) d. 
Mambas (Dendroaspis) 
4. Viperidae:  
These snakes have highly developed long curved, hinged, front fangs, 
which are channelised in the form of a hypodermic needle. There are two sub 
families— a. Viperinae or true vipers: Vipers and adders b. Crotalinae or pit 
vipers: Rattle snakes (Crotalus, Sistrurus), and Asian pit vipers (Trimeresurus, 
Hypnale).  
5. Hydrophidae:  
This family comprises sea snakes, which have short ﬁ xed fangs as in the 
case of the elapids.  Approximately 330 species of snakes exist in India, of 
which about 70 species are venomous (40 land snakes and 30 sea snakes). The 
commonest Indian venomous snakes are referred to as the “Big Four”, and 
comprise common krait (Bungaruscaeruleus), common cobra (Najanaja), saw-
scaled viper (Echiscarinatus), and Russell’s viper (Viperaruselli) Renal 
involvement is associated with bites from the last 2 families. 
COBRAS: 
 The common cobra is usually brown or black in colour.  It is a distinctive snake 
growing  up to 5 to 6 feet in length, with a distensible neck that can be expanded 
into a hood. On the dorsal side of the hood, there may be a monocellate 
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(monocle) or binocellate (spectacle) mark.   The former is more common in the 
Bengal cobra (Najakaouthia).  
The monocellate cobra is generally brown or black, with speckled or 
variegated, white or pale yellow appearance. It often has alternate wide and 
narrow, transverse, dark bands. Dorsal hood mark is a pale circle edged with 
black and has 1 to 3 spots; ventral hood mark has a pair of dark spots, or a wide 
dark band.    
Another variety of cobra that is encountered in the Indian sub-continent is 
the Andaman cobra (Najasagittifera).  The hood markings distinguish the cobra 
from other species, and its habit of rearing up when alarmed make it distinctive 
but not deﬁnitive, as other species do this, notably the Trinket Snake.  On the 
ventral surface of the hood are faint, broad, black stripes above which are two 
dark spots that extend over 3 to 4 scales. The head is small, and pupils are 
round.  The most important distinguishing feature of this snake is the fact that 
the 3rd supralabial shield touches the eye and nose shield. Also, a small wedge-
shaped scale (“cuneate”) is present between the 4th and 5th infralabials. 
Another important feature is said to be the presence of 3 small scales just behind 
each eye. 
KRAITS: 
 The common krait is a steel-blue snake growing up to 3 to 4 feet in length 
(sometimes up to 7 feet), with whitish bands or half-rings throughout its back 
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.Occasionally, it may be grey or dark brown in colour. The markings consist of 
paired white bands which may be less distinct anteriorly.   
The common krait has small dark eyes, and the pupils are almost 
invisible. The upper lip is white or yellow, while the belly is very white. The 
most distinctive features comprise the following: A chain of hexagonal large 
scales throughout the middoral aspect of the body . The subcaudals (ventral 
scales distal to the vent) are undivided, unlike other elapids. The 4th infralabial 
scale is the largest of the infralabials.  
VIPER:  
            The two species of vipers in India are Russel viper and saw scale viper. 
Russelviper  is a brownish, stout snake, growing up to several feet in length .  
The head is triangular, with a ‘V’ shaped mark (apex pointing forward), and is 
covered with small scales. Pupils are vertical. Fangs are long, channelised, and 
hinged, being erected at the time of striking .There are 3 rows of chained dark 
spots over the entire body. The Russell’s viper is known to hiss loudly when 
agitated. Like other vipers, it is viviparous. Russell’s viper is a nocturnal snake, 
but unfortunately for humans, during the daytime it often rests up under bushes, 
at the base of trees, and in leaf litter. It is therefore frequently encountered by 
rural workers as they carry out general agricultural activities. 
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The saw-scaled viper is a small snake, about 1½ to 2 feet long, and is 
usually brown in colour . Occasionally, the colour appears greenish. There is a 
wavy white line along the entire length of each flank, while diamond-shaped 
markings extend over the back, numbering usually 25 to 30. The head is 
triangular with small scales.  
A characteristic whitish, arrow-shaped or crow’s foot mark is often 
present on the head. The pupils are vertical. The saw-scaled viper is named as 
such because its scales are serrated. When agitated, it throws itself into a double 
coil (in the manner of a “ﬁgure of eight”), and rubs the coils together 
vigorously, producing a harsh, rasping sound, akin to the sound of a sandpaper 
being scraped over a rough surface. At the same time, it also hisses loudly by 
exhaling forcefully through the nostrils.  Like other vipers, the saw-scaled viper 
is viviparous.  The echis is an aggressive snake and may bite on the slightest 
provocation. 
The family Viperidae includes adders, pit vipers (like rattlesnakes, 
cottonmouths and copperheads), the Gaboon viper, green vipers and horned 
vipers.  
All vipers are venomous and have long, hinged fangs. 
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3.3 SNAKE VENOM: 
                  Snake venom
(48,49,50)
 is a special form of saliva that contains a range 
of zootoxins and is stored in something akin to our salivary gland. Once the 
venom is created and stored in these glands, it does not move back through the 
body, where it could infect other tissues, just as it does in their prey. The toxic 
venom is stored in these specially protected glands until it is moved down 
through narrow tubules in the fangs and delivered into the snake’s prey. 
 
PHOSPHOLIPASE A: 
                       Phospholipase A1 is a phospholipase enzyme which removes the 
1-acyl. Phospholipase A1 is an enzyme that resides in a class of enzymes called 
phospholipase that hydrolyze phospholipids into fatty acids.  It has a direct lytic 
and hemolytic effect and hydrolysis of phospholipase of RBC membrane and  
causes a sudden decrease in BP. 
CHOLINESTERASE
(51)
: 
                         It is either of two enzymes that catalyze the hydrolysis of these 
cholinergic neurotransmitters, such as breaking acetylcholine into choline and 
acetic acid.   It is found in cobras. It hydrolyses acetylcholine to cholic acid and 
acetic acid.  
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ACETYL CHOLINE-COBRA-CROTALIDAE 
                     Acetylcholine (ACh) is an organic chemical that functions in the 
brain and body of many types of animals, including humans, as a 
neurotransmitter
(52)
.It has a direct action on the heart and the neuromuscular 
junction. 
 PROTEINASE: 
                      Markedly present in vipers, Crotalidae. It leads to tissue damage 
and destruction. 
ANTI COAGULANT: 
                      It has anti coagulant effect because of proteolytic disintegration of 
fibrinogen. 
 COAGULANT EFFECT: 
               It has coagulant effect by converting Prothrombin into thrombin. 
NON ENZYMATIC COMPONENTS: 
Haemorrhagins (HR 1 AND HR 2) has direct action on endothelium containing 
procoagulant and anticoagulant effects . It causes very fast haemorrhage 
continued by vasodilatation of micro vessels, haemorrhages . 
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3.4 PATHOGENESIS OF ACUTE KIDNEY FAILURE: 
                      The exact pathogenesis of acute kidney failure is not correctly 
known, due to lack of animal models. The factors contributing are Direct 
cytotoxicity , bleeding , Hypotension, intravascular haemolysis ,DIC, 
microangiopathic haemolytic anaemia. 
Oligoanuria and bleeding manifestation were the most common clinical 
manifestation. Besides this hypotensive shock, cellulitis or feature of severe 
inflammation and regional lymphadenopathy also observed. Among unusual 
presentation about eight patients had herpes labialis and two patients had 
panhypopituiterism.  
Herpes labialis in SAKI
(41)
 patients was attributed to a possible 
immunologically altered state in those patients.  Between the two cases of 
hypopituitarism one case presented during the hospital stay and another case 
was diagnosed on a subsequent visit with deficiencies of gonadal, steroid, and 
thyroid axes. They showed marked improvement after replacement of anterior 
pituitary hormones. The probable mechanism was thought to deposition of 
fibrin microthrombi and hemorrhage in the pituitary gland resulting from the 
action of venom procoagulant enzymes
(54)
 and hemorrhagin. 
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DIRECT NEPHROTOXICITY: 
                              The pathogenesis of renal lesions is multifactorial and has 
been attributed to the nephrotoxicity of venom, hypotension, circulatory 
collapse, and intravascular hemolysis with hemoglobinuria, myoglobulinuria, 
DIC, hemolytic uremic syndrome, sepsis, and other factors such as 
hypersensitivity to venomous or antivenomous protein. Pathological 
investigations of human fatal cases revealed renal cortical necrosis, distal 
nephron  nephrosis, thrombotic microangiopathy, and acute tubular necrosis. 
 Experiments with I-125 labelled E. carinatus venom and venom antigen in 
human victims have shown that the venom is excreted in the urine, without 
essentially causing damage to the kidneys. There were slight changes in the beta 
N-glucosaminidase in patients bitten by Russells viper, without DIC, showing a 
direct toxic effect on renal function. 
 In a study, the administration of lethal dose of Russells’ viper or E.carinatus in 
rhesus monkey showed hemorrhages in kidneys and other organs and mild ATN 
in 20percent animals inside 24hrs. After a sub lethal dose more than 50percent 
animals developed ATN. Fibrin thrombi was seen in 50-75 percent of 
glomeruli. The histological findings and the coagulation abnormalities seen in 
the animals were similar to the human victims. 
16 
 
                               The strongest evidence is dose dependent reduction in Inulin 
clearance and increase in fractional excretion of sodium in the isolated perfused 
rat kidney due to russells viper venom. But this didntincluse morphological 
analysis of the kidneys. To obtain more information about direct toxicity in 
renal tissue ,Willinger et al studied combined functional and morphological 
changes in perfused rat kidney and complimented the studied in renal 
epithelium and mesangial cell cultures. 
 
 RVV Administration caused changes in the renal plasma flow, 
glomerular filtration rate, filtration fraction and tubular reabsorption of sodium 
were reduced and fractional excretion of sodium and water  increased. Both 
oliguria and subsequent polyuric phase was shown. On morphological analysis, 
the prominent pathology was in renal cortex. Extensive damage and loss of 
glomerular epithelial cella and endothelium was detected by basement 
membrane remaining. Ballooning and even rupture of glomerular capillaries 
was visible. 
Another prominent feature of RVV is its action on renal cortex and other 
zones along with its concerned vessels and muscle walls. The venom led to the 
complete lysis of the vascular smooth muscle layer of muscle cells. Only the 
basement membrane was left behind. There were different degrees of epithelial 
injury in all tubular segments. 
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In cell culture studies, RVV caused a complete destruction of confluent 
mesangial cells at lower concentration. In epithelial cell cultures, only higher 
doses caused discernible damage. Willinger et al thus demonstrated a direct 
dose dependent toxic effect of RVV on isolated perfused rat kidney, mostly 
against glomerular and vascular structures and on mesangial cells. 
In addition to that , myoglobinuria, sepsis and hypersensitivity to venomous or 
anti venomous protein may also lead to renal failure. Crescentic nephritis in 
patients who were bitten by puff adder also showed hypersensitivity to 
antisnake venom. Myoglobinuria usually occurs following a sea  snake 
envenomation which leads to necrosis of striated muscles and muscular 
paralysis. 
 
HYPOTENSION: 
Bleeding either into the tissues or external bleeding or loss of plasma into the 
bitten area can lead to hypotension and circulatory collapse. It is due to venom 
metalloproteinases that leads to degradation of the basement membrane proteins 
surrounding the vessel wall, leads to loss of integrity. Heamorrhagic toxins have 
been isolated from venom of several  snakes Viperidae and Crotalidae families. 
Hypotension is due to bradykinin release. In addition to that vasodilation and 
increased capillary permeability. Both as a result of direct and indirect effects of 
venom can aggravate the circulatory disturbances of shock. Viperapalestinae 
18 
 
venom causes shock by depressing the medullary vasomotor center. 
Bitisarietans causes hypotension byreducing myocardial activity , arteriolar 
vasodilation and increase of vascular permeability. Irrespective of the cause , 
hypotension and circulatory collapseresults in ischemic ARF. 
 
INTRAVASCULAR HEMOLYSIS: 
                                 Another factor that have pathogenetic importance in snake 
bite induced ARF is intravascular hemolysis. Hemolysis results due to 
phospholipase A2 which is found in almost all snake venoms
(55,56) and  ‘direct 
lytic factor’ found only in elapid venoms. Phospholipase A2 leads to hemolysis 
by direct hydrolysis of RBC membrane phospholipids or indirectly by the 
production of lysolecithin which has strong haemolytic effect  from plasma 
lecithin. 
                        Evidence of intravascular hemolysis by anemia,jaundice, 
reticulocytosis, raised plasma free HB, abnormal peripheral blood smear , 
present in 50percent by Russells viper and E.carinatus. In a study , using male 
wistar rats , severe hemolysis leads to increase in plasma LDH levels, free 
hemoglobin and late presence of hemolysed RBC casts in renal tubules after  
envenomation  of Bothropsjararaca. 
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                          Certain people have said that renal failure after a snake bite 
should be considered as HUS. However, while intravascular hemolysis is 
frequently observed, microangiopathic hemolysis is seen only rarely in 
hemolytic uremic syndrome. More than 70-80percent patients with snake bite 
induced renal failure only have ATN and they do not show glomerular and 
arteriolar changes which are characteristically associated with HUS. 
DISSEMINATED INTRAVASCULAR COAGULATION: 
                            The human hemostasis
(14)
 is kept in balance by a number of 
crucial interactions between blood proteins, platelets, endothelial cells and 
subendothelial structures. Snake venom proteins and peptides are commonly 
involved  in activating or deactivating these interactions. Snake venoms mainly 
from viper and pit viper families have  proteins that acts on  members of the 
coagulation cascade and the fibrinolytic pathway.    
Russells viper venom(RVV) contains a factor V activating serine 
proteinase, which is seperated from X activating protein also present in this 
venom. The enzyme (RVV-V) is a single chain glycoprotein which has a 
molecular weight of 26,100 possessing one glycosylation site near the carboxy 
terminal. RVV-V cleaves a single peptide bond to convert factor V to Va. 
Russells viper venom also has a potent activator of human coagulation factor 
X
(18)
 .Factor X activators have been isolated from Bothropsatrox and several 
20 
 
other snakes. Russells viper venom also activates factor IX by cleavage of a 
single peptide bond results in the forming of factor IXa. 
                                There are several prothrombin activators in snake venom. 
The activity of  group I members is not influenced by components of 
prothrombin activating complex. Ecarin from E.carinatus venom is the most 
studied member. Group II activators resemble factor Xa cleaves peptide bonds 
in prothrombin. It leads to active 2-chain thrombin. It is strongly stimulated by 
phospholipids and factor Va in the presence of CaCl2.These enzymes are 
present in all venoms of Australian elapid  snakes and the best one is from the 
tiger snake. 
               In contrast to that , the activators of group III only requires 
phospholipid and CaCl2 for the prothrombin activation. They do not require 
factor Va but seem to have a co factor slightly similar role which is tightly 
bound to Catalytic subunit . This class of activator is seen in Australian elapids 
and is represented by aHMWactivator from Taipan venom. 
Eventhough thrombin has several activities , some Snake venoms have the 
ability to clot fibrinogen and so called thrombin like. These are mostly found in 
venom of snakes from true vipers like Bitisgabonica. The fibribogen clotting 
enzymes of snake venom have been classified into fibrinopeptidases A and B 
from fibrinogen. 
21 
 
            One mechanism of snake venom proteins having anticoagulant action is 
attributed to protein C activation . Activated protein C degrades factors Va and 
VIIIA and therefore it has anticoagulant activity . Another mechanism of 
anticoagulation involves inhibition of coagulation of blood by factors like IX 
and X by the proteins from venom that binds to either or even both. At the end, 
anticoagulation is achieved by the action of the phospholipases
(58,59,60)
 from 
snake venom. It degrades the phospholipids that are involved in the formation 
of complexes that are very crucial for activating coagulation pathway. 
                            The enzymes that causes fibrinolysis  have been isolated from 
the venom of a number of North and South American  snakes that include 
rattlesnakes and copperheads from elapids like cobras and European vipers. The 
venom fibrinolytic enzymes classified are zinc  metalloproteinases as alpha and 
beta chain fibrinases. They contain a number of platelet active components that 
cause platelet aggregation and those that inhibits platelet aggregation.  
                                The final coagulation depends upon the balance between the 
procoagulant, anticoagulant, fibrinolytic and fibrinogenolytic components of 
venom.  DIC is a feature in patients who are bitten by Russell’s viper, 
E.carinatus,  and pit vipers. The DIC Is a major hemostatic abnormality is well 
recorded. The infusion of Russell’s viper or E.carinatus venom into a rhesus 
monkeys lead to abnormal coagulation profile  which suggests DIC within 
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2hours of injection of lethal dose of venom, but these changes occurred few 
weeks  after sub lethal envenomation. 
 
   The presence of fibrin thrombi in the renal microvasculature and in the 
glomerular capillaries , and the records of MAHA and thrombocytopenia
7
 in 
patients with necrosis of cortical tissues. It strongly suggests that DIC plays a 
major  role in cortical necrosis induced by snake bite. It initiates a reaction 
which involves coagulation ,fibrinolytic , kinin and complement systems. The 
alterations that are induced by venom leads to coagulation and to fibrin thrombi  
deposition in vessels. The fibrin deposition which is intraglomerular of lesser 
degree is being suspected as causing ATN via transient  hemodynamic change. 
The role of factors that cause ARF was shown in an experimental model by 
Burdmann et al. They injected 0.4mg/kg of Bothropsjararaca venom 
intravenously into male Wistar rats . It produced morphological and functional 
changes that are similar to those observed in human snake bite induced 
ARF.There was an acute and sjgnificant reduction in the GFR, urine output , 
renal plasma flow and serum fibrinogen levels. It causes intravascular 
hemolysis and it shown by a significant decrease in hematocrit  and an increase 
in plasma LDH levels and free hemoglobin . The microscopy showed massive 
fibrin deposition in glomerular capillaries apart from the proximal and distal 
tubular necrosis and RBC cell casts in renal tubules. In this model, ischemia that 
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is related to glomerular coagulation and intravascular hemolysis were the major 
factors that causes a decrease in the GFR , although direct venom 
nephrotoxicity could not be excluded. 
3.5 SIGNS AND SYMPTOMS 
(4)
: 
Venomous Snakebite  
1. Without Envenomation: 
 a. It is well known that even when a highly venomous snake bites a human, 
serious envenomation may not occur. In fact, it has been suggested that 20 to 
50% of venomous bites are not attended with serious toxicity. 
 b. Reasons for lack of envenomation in venomous bites include the following:  
 
inﬂicted on shod feet or heavily clothed parts.  
-on bites often result in efﬁcient injection of 
venom, while sideswipes may cause some (or all) of the venom to escape 
outside the bitesite. 
cial bite: Since humans do not constitute normal prey for most 
venomous snakes, they bite only to defend themselves before making a quick 
get-away. In such instances, the snake often deliberately does not bite deeply, 
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but instead only strikes superﬁcially, thereby conserving precious venom for its 
genuine prey. 
 2. With Envenomation: 
 a. Colubrid bite  
comprise pain, oedema, erythema, ecchymosis and numbness, which resolve 
over one to two weeks.   
tallic taste, and headache have also been 
reported. 
 b. Elapid bite 
local 
manifestations . Pain and swelling are relatively less intense, and often there is 
only a serosanguinous ooze from the bitesitewith mild pain, tenderness, and 
blistering. However, cobras can occasionally cause significant local swelling, 
blistering, and regional lymphadenopathy. The lesion may emit a putrid smell, 
and break down with loss of skin and subcutaneous tissue .Elapid bites 
sometimes cause early onset of gangrene (of the wet type), while viperid bites 
progress more slowly, and the gangrene is usually of dry type. Secondary 
infections, e.g. tetanus, gas gangrene, etc. are relatively less common. 
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ffects: Neurotoxicity is the dominant clinical feature of elapid 
bites. Symptoms usually occur earlier (within 15 minutes to ½ hour) in cobra 
bite, while they are often delayed (up to several hours) in krait bite. –
Preparalytic Stage— - Vomiting -Ptosis (preceded by contraction of frontalis 
muscle) -Blurred vision, external ophthalmoplegia - Paraesthesiae around the 
mouth - Hyperacusis -Headache, myalgia - Vertigo -Hypersalivation (due to 
autonomic stimulation). – 
 Paralytic Stage— - The facial muscles, palate, jaws, tongue, vocal cords, neck 
muscles, and muscles of deglutition all become progressively ﬂaccidly 
paralysed. Many patients find it difficult to open their mouths and speak.  -
Respiratory arrest may occur due to obstruction of upper airway by the 
paralysed tongue or inhaled vomitus, or due to paralysis of intercostal muscles 
and diaphragm. Paradoxical respiration, as a result of the intercostal muscles 
becoming paralysed is said to be a frequent sign.  -Although a patient appears 
unconscious, most are able to follow simple commands as noted by purposeful 
movement of the ﬁngers or toes. Loss of consciousness and convulsions are 
terminal phenomena resulting from hypoxaemia. -Roughly half of patients 
bitten by Najakaouthia (monocellate cobra) do not sustain envenomation. Local 
pain and swelling develops within 2 to 3 hours and becomes maximal in 24 to 
48 hours. Blisters and skin discolouration may develop, and may be followed by 
necrosis of subcutaneous tissue with sloughing. Neurotoxicity, if it develops, 
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generally begins 1 to 5 hours after envenomation, but may be delayed as long as 
19 hours. Cranial nerve palsy is followed in some patients by generalised 
weakness and respiratory failure. - Renal complications are rare in elapid bites. -
Although rarely reported in literature, disorders of platelet aggregation and 
coagulation-ﬁbrinolysis system may occur after envenomation by cobras. 
Disseminated intravascular coagulation (DIC) may occur after bites by these 
snakes. -Coral snakes usually cause milder manifestations as compared to other 
elapids. Even substantial envenomation is associated with full recovery, 
following timely intervention. 
 c. Viperid bite 
–Pitless as well as pit vipers cause marked local manifestations 
which develop rapidly, usually within ½ hour, but may occasionally be delayed 
for several hours.  – Swelling ﬁrst appears around the bite site, and then spreads 
quickly to involve the whole limb and adjacent trunk. There is associated pain, 
tenderness, and regional lymphadenopathy. Bruising is commonly seen over the 
path of superﬁcial lymphatics and over regional lymph nodes. Persistent 
bleeding from bite site is a constant feature.  –Blisters begin to appear in about 
12 hours in and around the bite site, progressing subsequently to involve the 
entire limb. They may contain either clear or bloodstained ﬂuid. In about 10 to 
15% of the cases, extensive necrosis of skin, subcutaneous tissues, and muscles 
may occur.  –Raised  intracompartmental pressure adds to the problem in 
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regions with tight fascial compartments such as anterior tibial compartment. 
This is characterised by severe pain, tense swelling, subcutaneous anaesthesia, 
and increased pain on stretching intracompartmental muscles.  
–Haemostatic abnormalities are very characteristic of 
viperid bites. The ﬁrst evidence of this is persistent bleeding from the bitesite. 
Haematuria may be seen within a few hours of the bite . Later gingival bleeding 
occurs , followed by epistaxis, haemoptysis (relatively rare), haematemesis, 
ecchymoses, intracranial and sub-conjuctival haemorrhages, and bleeding into 
the ﬂoor of the mouth, tympanic membrane, gastrointestinal tract, and genito-
urinary tract. Bleeding into anterior pituitary (causing a Sheehan-like syndrome) 
has been reported. Subarachnoid haemorrhage manifests as severe headache and 
meningism, while intracerebral haemorrhage may cause hemiplegia, loss of 
consciousness, and convulsions.  Retroperitoneal and intraperitoneal 
haemorrhages cause abdominal distension, tenderness, and peritonism, with 
signs of haemorrhagic shock. 
Viperid envenomation is almost synonymous with incoagulable blood, which 
results from deﬁbrination. Intravascular haemolysis causing haemoglobinuria 
and renal failure 
(62)is a frequent occurrence, especially in bites by Russell’s 
viper. Acute renal failure is often associated with the presence of DIC which 
results in severe renal tubular and cortical necrosis with widespread 
microvascular fibrin deposition (microthrombi). It is suggested, however, that a 
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direct toxic effect produced by the venom of Russell’s viper may produce renal 
damage. The hump-nosed pit viper can also cause renal failure, but the saw-
scaled viper usually does not. – Hypotension is an important manifestation in all 
viper bites and is usually accompanied by tachycardia, unless the venom has 
affected the heart directly or reﬂexly, in which case the pulse may be slow or 
irregular. – A study on saw-scaled viper bites has indicated that haemorrhagic 
manifestations could more commonly be due to primary pathological 
ﬁbrinolysis (PPF) than disseminated intravascular coagulation (DIC). The 
signiﬁcance of this assertion is that administration of heparin which is the 
treatment of choice for DIC, may actually worsen the condition if it is due to 
PPF. – Cardiotoxicity(9) (which may be seen in elapid bite also) produces a wide 
variety of ECG changes. It is important to note that ptosis and neurological 
symptoms
(5)
 may occur in the case of Russell’s viper bite , and every clinician 
must be alert to this possibility. Generalised ﬂaccid paralysis can develop after 
envenomation. Neurotoxic effects are caused by the presence of phospholipases 
A2 with presynaptic neurotoxic activity. Conversely however, kraits and cobras 
do not cause coagulation abnormalities. 
d. Hydrophid bite  
-known to produce minimal local 
effects. The bite itself is often painless and the victim may not even realise he 
has been bitten.  However teeth are often left behind inthe wound. Local 
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swelling is negligible, and regional lymphadenitis usually does not occur. Fang 
marks may appear as one, two or more small circular dots, as though made by a 
pin or hypodermic needle. It is important to note that in some cases, there may 
be no clear fang marks, but a vague scratch mark, and yet serious poisoning 
may occur. 
–The dominant clinical feature is myalgia with stiffness 
and tenderness of muscles, which become apparent in ½ hour to 2 hours. This is 
due to rhabdomyolysis, since hydrophid venom is predominantly myotoxic. 
Myoglobinaemia and myoglobinuria occur, resulting in acute tubular necrosis 
and renal failure. A “ﬁxed” speciﬁc gravity of 1.010–1.013, together with a low 
urine volume output, myoglobinuria
(12)
, and progressively rising blood urea are 
indicative of impending acute renal failure in the setting of sea snake 
envenomation. –Trismus is an early feature. Passive stretching of muscles is 
painful. Later, ﬂaccid paralysis develops, beginning with ptosis (as in elapid 
bite). –Hyperkalaemia may be present due to release of potassium from 
damaged muscles. This may be severe enough to cause cardiac arrest. Tall, 
peaked T waves and QRS prolongation suggest severe hyperkalaemia. –Other 
effects may include dizziness, nausea, vomiting, headache, and diaphoresis. –
Neurotoxicity may include ptosis, ophthalmoplegia, dysarthria, blurred or 
double vision, mydriasis, inability to sit unassisted, depressed muscle stretch 
reflexes, and flaccid paralysis. In some cases, paralysis of respiratory muscles 
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causes death due to respiratory failure. Consciousness is usually retained till the 
end. The fatality rate is estimated to be about 3%. Failing vision is considered to 
be a terminal sign. 
REGIONAL SYMPTOMS AND SIGNS IN THE BITTEN PART: 
The signs include fang marks, local pain, local bleeding, bruising, 
lymphangitis, lymph node enlargement, inflammation, blistering, local 
infection, abscess formation, necrosis. A valuable sign of viper bite is local 
swelling and  bite marks and deeper especially in viper bite. Local swelling 
rarely occurs with Asian Cobra bite. 
3.6  GENERALISED SYMPTOMS AND SIGNS: 
 GENERAL: 
It may include nausea, vomiting, abdominal pain, weakness, drowsiness, 
and prostration. Fright reaction that may develop in patients and it must be 
differentiated from neurotoxicity. 
CARDIOVASCULAR: 
It is mainly seen in patients bitten by a Viper. It may include  collapse, 
hypotension, shock, cardiac arrhythmias, coronary vasoconstriction, pulmonary 
edema and cardiac arrest. 
Common ECG changes in snake bite : 
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Sinus bradycardia ,Sinus tachycardia ,Sinus arrhythmia, Tall T waves , ST 
depression %1mm with ﬂ at or inverted T in all chest leads , ST depression 
%1mm with T inversion in inferior leads, or in anterior leads, ST elevation in 
leads V1 to V6, I, aVL, Q wave V1 to V4 and ST depression in II, III, aVF First 
degree or second degree heart block. 
NEUROLOGICAL: 
Neurotoxicity may include ptosis, ophthalmoplegia, dysarthria, blurred or 
double vision, mydriasis, inability to sit unassisted, depressed muscle stretch 
reflexes, and flaccid paralysis. In some cases, paralysis of respiratory muscles 
causes death due to respiratory failure. Consciousness is usually retained till the 
end. Failing vision is considered to be a terminal sign. 
MUSCULAR BREAKDOWN: 
               It is seen in usually patients bitten by sea snake. They develop 
generalised pain, stiffness, tenderness of muscle ,trismus, hyperkalemia ,cardiac 
arrest and acute renal failure. 
RENAL: 
               It develops in patients bitten by the snakes belonging to families 
Viperidae and Hydrophidae family. Patients usually manifest with loin pain, 
hematuria, hemoglobinuria ,myoglobinuria, oliguria and also symptoms of 
uremia. Ischemia occurs due to hypotension and DIC and nephrotoxic effect of 
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the venom. Pigment nephropathy is also associated with rhabdomyolysis and 
intravascular hemolysis which leads to ATN . It may also lead to cortical 
necrosis and renal failure which is usually caused by Russells viper. 
HEMORRHAGE AND HEMOTOXICITY: 
Haemostatic abnormalities are very characteristic of viperid bites. The  
ﬁrst evidence of this is persistent bleeding from the bitesite. Haematuria may be 
seen within a few hours of the bite . Later gingival bleeding occurs , followed 
by epistaxis, haemoptysis (relatively rare), haematemesis , ecchymoses, 
intracranial and sub-conjuctival haemorrhages, and bleeding into the floor of the 
mouth, tympanic membrane, gastrointestinal tract, and genito-urinary tract. 
Bleeding into anterior pituitary (causing a Sheehan-like syndrome) has been 
reported. Subarachnoid haemorrhage manifests as severe headache and 
meningism, while intracerebral haemorrhage may cause hemiplegia, loss of 
consciousness, and convulsions.  Retroperitoneal and intraperitoneal 
haemorrhages cause abdominal distension, tenderness, and peritonism, with 
signs of haemorrhagic shock. 
ENDOCRINE: 
In acute phase conditions patients develop hypoglycemia and shock. In 
chronic phase  they may develop weakness, loss of secondary sexual hair, 
amenorrhoea, testicular atrophy, hypopituitarism.  
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  LONG TERM COMPLICATIONS: 
Due to loss of tissue by sloughing and surgical debridement at the site of 
bite , it results in chronic ulceration, infection, osteomyelitis, arthritis which 
may persist causing physical disability. There may be malignant transformation 
in skin ulcers after several years. 
In Russell’s vipers bite, there occurs CRF after bilateral cortical necrosis and 
chronic panhypopituitarism and diabetes insipidus. In patients who suffered 
intracranial hemorrhages , chronic neurological deficits are  seen. 
3.7 PATHOGENESIS OF AKI 
(45) 
IN SNAKE BITE: 
RENAL HISTOLOGY: 
                         Renal histology mostly shows either an acute tubular or cortical 
necrosis. Sevaral glomerular changes have also been described but their 
significance is unknown. 
ACUTE TUBULAR NECROSIS: 
                          It is the most common lesion in 70-80 percent of patients with 
ARF. The tubules appear dilated and lined by flattened epithelium on light 
microscopy. In severe cases there is cell necrosis and desquamation of necrotic 
cells from basement membrane. In tubular lamina, hyaline granular and pigment 
casts are seen. Different degrees of interstitial edema, heamorrhage and 
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inflammatory cell infiltration are present. Regenerating tubular epithelium were 
revealed in tubular epithelium. Usually intrarenal blood vessels are not affected. 
                           Proximal tubules show dense intracytoplasmicbodies 
representing degenerating organelles or protein resorption droplets on 
ultrastructural examination. Small areas are denuded on the basement 
membrane. There are several dilated endoplasmic reticulum and many 
degenerating organelles in the distal tubular cells. Apoptosis indicates a high 
cell turnover and it is a prominent feature. The fibroblasts seem to be active in 
the interstitium. They have increased number of organelles and cytoplasmic 
processes. Mast cells as well as Eosinophils show partial degranulated and 
granulated forms.  
                                     Eventhough the blood vessels appear normal under light 
microscopy, ultrastructural abnormalities were noticed in both large and small 
caliber vessels. Medullary vessels are severely affected with markedly 
swollenendothelial cells with focal necrosis obliterating the lumen. The smooth 
muscle cells have cytoplasmic vacuoles which maybe empty or filled with 
granular material. The severe vascular lesions, distal tubular apoptosis and 
presence of mast cells, eosinophils, active fibroblasts in the interstitium are 
some of the features which have not been seen in ATN due to other causes.  
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ACUTE CORTICAL NECROSIS: 
          In the bites of E.carinatus there may be bilateral diffuse or patchy cortical 
necrosis. It is more common in Indian patients than among patients in Thailand 
for reasons unknown. The prominent feature in these patients Is the presence of 
fibrin thrombi. A narrow subcapsular rim of cortex escapes necrosis. The area 
under this shows glomerular and tubular necrosis. The necrotic zone is bordered 
by an area of hyperemia and leukocytic infiltration. There may be calcification 
of the necrotic areas in later stages. The numbers of glomeruli spared are 
varying in patients with patchy cortical necrosis. As it heals fibroblastic 
proliferation and organisation of the thrombi are seen. Renal ultrastructure in 
cortical necrosis is studied in two patients bitten by Russell’s viper.  
                                   In one patient, there was glomeruli with collapsed 
capillary basement membrane and denuded foot processes in a biopsy taken 
after 10days of bite. No viable mesangial or endothelial cells was identified but 
certain swollen cells were seen .They maybe of endothelial origin. Necrosis of 
peritubular capillaries and endothelial swelling of small arterioles were present. 
In the second patient, the urinary space contained unidentified cells which had 
large cytoplasmic vacuoles. They were found in the biopsy done after 31days. 
The tubular basement membrane was thickened and the cortical tubules were 
lined by flattened epithelium, with large nuclei and a dilated endoplasmic 
reticulum. There was also fibroblastic proliferation in the interstitium.  
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GLOMERULAR LESIONS: 
Its still a controversial whether or not specific glomerular lesions occur. 
Proliferative glomerulonephritis was reported in patients bitten by E.carinatus 
by Sand and Purandare. After that Seedat et al reported two patients   with 
crescentic glomerulonephritis due to puff adder bites presenting as acute renal 
failure. These workers ascribed these lesions to an allergic reaction to snake 
venom because renal lesions of proliferative nephritis with crescents had 
developed within 24-48hrs. Two patients with crescentic glomerulonephritis 
were described by Sitprija and Boonpucknavig after Russell’s vipers bite. In a 
study with 38patients who were bitten by green pit viper or Russell’s viper, 
thickening of the mesangial areas and mild mesangial proliferation were 
observed in most of the patients by the authors. They also observed diffuse 
glomerular hypercellularity. Other observed glomerular changes are endothelial 
swelling, ballooning of capillaries, mesangiolysis and splitting of glomerular 
basement membrane . But however the importance is difficult to understand. 
IgM, C3 and fibrin deposits were seen in immunofluorescence microscopy. In 
some cases, a diffuse and intense mononuclear cell infiltrate has been noted in 
the interstitium, which suggests acute interstitial nephritis. 
MANAGEMENT: 
Immediately after the bite, first aid treatment is carried out either by the patient 
or someone else. Certain methods like cauterisation, incision, excision, suction 
37 
 
by mouth, vacuum pumps, chemical application, cryotherapy, electric shock 
have been rejected. Bandage application is not advised due to lack of proper 
techniques and increased local effect of venom if brought late and 
ineffectiveness of the bandage, if the bitten limb is mobilized. It should be 
splinted after bite. Upper limb also should be splinted in a gravity neutral 
position at the level of heart.  
Rapid clinical assessment regarding the airway, breathing and circulation after 
the patient reached the hospital. Level of conciousness should be assessed. 
When the patient presents with a shock urgent intervention should be done. It is 
done even for cardiac arrest precipitated by hyperkalemia, septicemia and renal 
failure. 
The wounds should be cleaned and for under immunised and non-immunised 
patients, administration of tetanus toxoid or tetanus immune globulin should be 
considered. 
 Venous blood should be drawn from an unaffected extremity in a dry, small 
vessel and they should be given intra venous fluid. The blood is left undisturbed 
for 20minutes at room temperature. After that the vessel is tilted and the blood 
is uncoagulated which proves that it is viperine species bite and rules out 
Elapids. Then the blood is sent for complete blood count, peripheral smear, liver 
function test , blood urea, serum creatinine, CPK and ABG. 
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In systemic envenomation, neutrophilia is seen. Heamoconcentration is present 
due to capillary permeability and thrombocytopenia
(6)
 in viper bite. Hematocrit 
is decreased due to blood loss or intravascular hemolysis. When MAHA is 
present and plasma is pinkish in hemoglobinemia and myoglobinemia, 
fragmented RBCs are seen in peripheral smears.  
      There is acidosis and blood urea, serum creatinine are elevated when renal 
failure develops. Proteinuria and hematuria is seen in urine. Evidence of 
hyperkalemia, ST-T changes, AV block are seen n electrocardiogram ,and chest 
X ray  shows pulmonary edema, pneumonia, pulmonary patchy opacities. It is 
due to alveolar hemorrhages due to viper bite. Enzyme immunoassay 
methodology (IgG-based sandwich ELISA and indirect competitive inhibition 
ELISA) has been optimised for the detection of cobra and krait venom.  
3.8ANTI VENOM TREATMENT: 
Anti venom is immunoglobulin purified from serum or plasma of a horse 
or sheep that has been immunised with venoms of one or more species of 
snakes. Only polyvalent ASV is available in India and it neutralises venom of 
4important snakes in India; namely Cobra, Common Krait, Russell viper and 
saw scaled viper. Though many researches, preparing ASV by human 
recombinant DNA technology is still not successful. 
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INDICATIONS FOR ASV: 
Reid’s criteria (modified by Persson) for antivenom therapy are as follows: 
Prolonged or recurring hypotension, Persistent or recurring shock in spite of 
treatment, Pronounced leucocytosis, Protracted gastrointestinal symptoms, 
Acidosis, ECG changes, Raised serum creatine phosphokinase, Early extensive 
swelling in adults, Haemolysis, Pregnant women, small children. 
Before emerging out with an anti venom it is safe and desirable to wait 
for clear evidence of systemic envenomation. Allergic reactions occurs  in 15% 
of patients, although fatal anaphylaxis rarely occurs. A matter of controversy is 
that skin test with horse serum because it delays therapy and itself causes 
anaphylaxis and serum sickness and has been demonstrated to have a 10 to 
36percent false-negative rate and a 33percent false positive rate. 
When hemostatic abnormalities are there ,ASV is given. They are 
spontaneous systemic bleeding, prolonged 20min WBCT, thrombocytopenia
(13)
, 
and elevated FDP or D dimer neurotoxic signs like ptosis, external 
opthalmoplegia and paralysis , cardiovascular abnormalities like hypotension, 
shock, heart failure and pulmonary edema. It is given by supporting lab 
evidences of systemic envenoming and generalised rhabdomyolysis, Acute 
renal failure and signs of local envenomation. Speed of swelling indicates the 
severity of local swelling for ASV administration.  
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All the patients in whom ASV is indicated should receive it. Care should 
be taken of previous ASV allergy and history of atrophy. They should receive 
S/C adrenaline, IV anti histamines and steroids. 
 
3.9 DOSES AND ADMINISTRATIONS: 
1. Two methods of antivenom administration are recommended: 
     IV injection: 2 ml/ minute IV infusion or  5–10ml of isotonic fluid/kg 
body weight  
2. Haemotoxic/Neurotoxic Envenomation (< 3 hrs since bite): 10 Vials 
ASV  
3. Haemotoxic/Neurotoxic Envenomation (> 3 hrs since bite): 7 Vials 
ASV  
 No further antivenom is given over the next ﬁve hours 
Storage of antivenom—Antivenom must be stored in a refrigerator. Lyophilised 
antivenoms stored at below 8ºC usually retain their activity up to 5 years or 
more.  Reconstituted solutions remain stable up to 48 hours. Diluted solutions 
should be used within 12 hours of dilution. 
Several anti snake venom preparations are available internationally. In India, 
ASV producers belong to both Public as well as Private sector.  
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       ASV should be given as early as possible and if it is delayed more than 2hrs 
it will not reverse the local effects of the venom. Once initial dose is 
administered no further ASV is given for 6hrs. 
        20 WBCT test every 6hrs will determine if additional dose of ASV is 
required. ASV may be repeated till the coagulation profile is corrected. But 
patients who continue to bleed briskly, initial dose of ASV is repeated within 1 
to 2hrs. 
METHODS OF ADMINISTRATION: 
          It can be given IV at the rate of 2ml per minute or diluted in 100ml 
normal saline and given over 1hr. As the half life of Indian ASV is around 90hr, 
there is no requirement to extend the administration period. Local 
administration at the bitten site is not recommended. 
 
 RESPONSE TO ASV: 
           If adequate dose of ASV has been given that the patient feels better. 
Nausea, headache, generalised ache disappears. Spontaneous systemic bleeding 
stops in 15 to 30mins .Blood coagulability restored in 3 to 9hrs as measured by 
20min WBCT. Shock improves in first 30 to 60mins and arrhythmias may 
resolve. Neurotoxic symptoms begin to improve as early as 30mins. Active 
hemolysis may cease within a few hrs and urine returns to normal. 
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ASV Reactions: 
 Early (anaphylactic) reaction: Develops in 10 minutes to 1 hour of beginning 
the antivenom therapy.  It begins with cough, urticaria, tachycardia, 
palpitations, nausea, vomiting, headache, and fever. The full-blown 
anaphylactic reaction is characterised by hypotension, bronchospasm, and 
angioedema. Treatment involves administration of adrenaline subcutaneously, 
0.5 to 1 ml of 0.1% solution (1 in 1000) for adults; 0.01 mg/kg for children. 
This is followed by an antihistamine (e.g. chlorpheniramine maleate, 10 mg in 
adults; 0.3 mg/kg in children). - Pyrogenic reaction: Develops in 1 to 2 hours of 
beginning the therapy. It is characterised by chills, goose fleshing, shivering, 
rise in temperature, sweating, vomiting, and diarrhoea. Treatment involves 
fanning, tepid sponging, hypothermia blankets, or antipyretic drugs such as 
paracetamol (5 mg/kg orally, as suppository, or via nasogastric tube). - Late 
(serum sickness) reaction: Develops about 7 days after treatment.  It usually 
responds to antihistamines and corticosteroids. 
3.10. COMPLICATIONS OF SNAKE VENOM &MANAGEMENT: 
Hypotension and shock are treated with ASV, plasma expanders and 
vasoconstrictors. Russell’s viper bite results in acute pituitary, adrenal 
insufficiency & responds to hydrocortisone. Hemostatic disturbances respond 
well to ASV. ASV is given to neutralize procoagulant and toxins. FFP, 
cryoprecipitate, fresh whole blood are given to restore coagulability. Bitten limb 
nursed in most comfortable position, slightly elevated. 
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Prophylactic antibiotics like penicillin and metronidazole should be given. If 
wound is incised use broad spectrum antibiotics.  
RENAL FAILURE is due to multi factorial causes. Early correction of shock & 
ASV is important to avoid ARF. Situations of oliguria where ARF not 
established, frusemide with fluid challenge or mannitol challenge can be tried. 
MC cause of ARF is ATN and has good prognosis. 10% of cases develop ACN 
& it is bad prognosis. 
Indication for dialysis
(36)
: 
Patient is taken up for dialysis when his general condition deteriorates due to 
hyperkalemia, pulmonary edema, severe acidosis and when the renal parameters 
are raised. In non-oliguric renal failure, the decision is done based on raising 
renal parameters. Hemodialysis
(37)
 is done in patients with normal hemodynamic 
status. Those who are hemodynamically unstable, Peritoneal dialysis
(39)
 is done. 
Patient with AKI
(38)
 recovers in 3 weeks. If the patient does not recover think of 
Cortical Necrosis and Biopsy is medial. Prognosis of patients with renal failure 
is very good and they recover with appropriate treatment. Prognosis of patients 
with cortical necrosis is poor. They go in for Chronic Kidney Disease
(23)
. 
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4.  MATERIALS AND METHODS 
Setting   : The work was carried out in the Dept.of Internal Medicine 
department and IMCU  of Thanjavur Medical College, Thanjavur. 
Design of the study   :  Observational study  
Period of the Study   :  Six months – March 2017 to August 2017  
Sample size   :  50 cases (25cases and 25 controls)  
Ethical committee approval   : The present study was approved by the 
Institutional Ethical committee.  
 
INCLUSION CRITERIA: 
Patients with snake bite
 
, developing Acute Kidney Injury. 
 
EXCLUSION CRITERIA: 
1) Known Hypertensive and on treatment. 
2) Known Diabetic and on treatment 
3) Chronic history of NSAID intake 
4) Past history of renal disease. 
5) Previous Ultrasonogram evidence of Chronic Kidney disease
(20)
. 
 
 
45 
 
 
Consent:  
                 The study group thus identified by the above criteria (inclusion and 
exclusion criteria) were first instructed about the nature of the study. Willing 
participants were taken up after getting a written informed consent from them.   
Study Subjects and Controls:  
                   Fifty cases with history of snake bite  patients who got admitted in  
the Dept of Internal medicine  of Thanjavur Medical college for the period of 
six months from March 2017  to August 2017 formed the study group. Out of 
these 25 patients were kept as controls and 25 patients kept as cases and they 
were assessed on  who progressed to AKI
(24) 
. 
Details of study subjects: 
 All the cases were subjected to careful history taking and physical 
examination  and biochemical parameters were done on the day of presentation . 
 
CLINICAL EXAMINATION:  
A thorough physical examination was done tolook for local and systemic 
features of envenomation. 
EVIDENCE FOR REGIONAL ENVENOMATION: 
Site of snake bite is examined for presence of fang marks, cellulitis, 
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bleeding from site of bite, local necrosis, blistering, gangrene, regional 
lymphnode enlargement and evidence for compartment syndrome.All Vital 
signs looked for. 
 
EVIDENCE FOR SYSTEMIC ENVENOMATION: 
Features of bleeding manifestations – gum bleeding, epistaxis, 
ecchymosis ;Features of NeuroparalysisAzotemia / Uremic symptoms. 
 
INVESTIGATIONS: 
1.blood urea 
2.serum creatinine 
3.urine albumin 
4.platelet count
(2) 
 
Patients underwent physical examination daily. Pulse rate, Blood pressure,Urine 
output, Respiratory rate and features of envenomation were monitored daily. 
Blood specimen was taken everyday till discharge or death to measure 
sodium,potassium, urea, creatinine, bleeding time, clotting time, platelets and 
for patients undergoing dialysis, pre-dialysis and post-dialysis Urea and 
Creatinine measured for each cycle. 
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TREATMENT GIVEN: 
1. Injection Tetanus Toxoid 0.5ml subcutaneous on admission. 
2. Cleaning of the wound and area with soap and water. 
3. IV line secured for fluids and ASV. 
4. Specific treatment Inj ASV IV bolus and followed up doses depending upon 
the class of envenomation and biochemical parameters. Bite to ASV time noted. 
5. Repeated doses of ASV based on signs of envenomation and 
biochemical parameters. 
6. Maintenance of fluid volume, blood pressure. 
7. Drugs Ampicillin, cefotaxime, metronidazole given in regular dose and dose 
adjustment has done depending upon renal status. 
8. Observation. 
9. Patient having evidence of Acute Kidney Injury
(30)
 were identified. 
10. Dialysis program based on volume overload, urine output status, clinical 
azotemia, uremic symptoms and renal biochemical parameters. 
11. Repeated PD/HD depending upon the renal improvement. 
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5. STATISTICAL ANALYSIS. 
a) The data were incorporated into statistical software and analyzed by 
Graph Pad prism version 5. 
b) The data were expressed as mean with standard deviation for comparing 
the parameters between the groups. 
c) The data were expressed as absolute numbers with percentage for 
describing the frequency of the parameters in case and control groups. 
d) The unpaired  ‘t’ test or Mann Whitney ‘U’ test was used to compare 
means between the case and control groups for normally distributed and 
non-normally distributed data, respectively. 
e) Fisher’s exact test was used to find the statistical difference between the 
proportions. 
f) P<0.05 was considered statistically significant difference. 
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6. RESULTS 
6.1. AGE DISTRIBUTION OF THE STUDY SUBJECTS: 
In our study of 50 patients, the total number of patients included under cases 
and controls were 25 each. The cases were the subjects who developed the 
elevated renal parameters after snake bite and controls were the subjects with 
normal renal parameters after snake bite injury. 
The distribution of frequency of age in years was divided into six groups, 
namely, less than 20 years, 20 to 30 years, 31 to 40 years, 41 to 50 years, 51 to 
60 years and > 60 years in cases and control groups. The absolute numbers with 
percentages of age in years between cases and controls based on category is 
represented in table 1.  
In case group, the majority of the patients are of 41 to 50 years (n= 10, 40%), 
followed by < 20 years category (n=4, 16%) and the age category of 20-30 has 
least frequency (n=2, 8%).  
In controls, the majority of the patients belong to the 31-40 years group (n=8, 
32%) and 50 – 60 year group (n=8, 32%) and the age category of < 20 years and 
> 60 years have no subjects. 
The overall mean age of the control group is 41.5 years with standard deviation 
of 12.1 years and in the case groups the mean age is 41.9 years with standard 
deviation of 16.3 years. The mean of both the age groups were compared by 
unpaired ‘t’ test and the p value obtained was 0.92. Hence, both the groups are 
similar in respect to age in years. 
When overall the age distribution was considered without dividing into groups, 
with the sample of 50 subjects, most of the patients admitted with snake bite  in 
our study falls under 41 to 50 years of group (n=13, 26%) followed by 31 to 40 
and 51 -60 years group (n=11 ,22%). The age group of > 60 years has least 
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frequency distribution (n=3, 6%). The frequency distribution of overall age in 
years is represented in figure1. 
 
Table 1: Frequency distribution of age of patients in the study subjects. 
S.No Age category in years 
Cases 
(n=25) 
Controls (n=25) 
n % N % 
1 <20 years 4 16 0 0 
2 20 – 30  years 2 8 6 24 
3 31 – 40 years 3 12 8 32 
4 41 – 50 years 10 40 3 12 
5 51 – 60 years 3 12 8 32 
6 >60 years 3 12 0 0 
 Mean age with SD 41.9 (16.3) 41.5 (12.1) 
 
Foot note: The data are expressed as mean with standard deviation.  The total n 
in the study sample is 50. The mean age between the groups are compared by 
unpaired ‘t’ test and the p value is 0.92 (Not significant). 
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Figure 1: 
Frequency 
distribution 
of age of 
patients in 
the study 
subjects 
(Overall). 
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6.2. GENDER DISTRIBUTION OF SUBJECTS IN THE STUDY. 
The proportions of gender based on group in our study were shown in 
table 2. In the case group of 25 subjects, the male subjects were 76 % (n = 19) 
and the female subjects were 24 % (n=6). The proportion of male subjects was 
numerically higher than the female subjects in the case group. 
Similarly, in control groups of 25 subjects, the male subjects were 68 % (n=17) 
and the female subjects were 32 % (n=8). The proportions of male subjects was 
numerically higher than the female subjects in the control group 
When all these proportions are compared between the groups based on gender 
by using Fisher’s Exact test, the p value obtained was 0.87 (Not significant). 
Hence the gender proportions are equally distributed between the case and 
control group. 
When the overall sample of 50 subjects was analyzed without dividing into 
groups, the male subjects were 72% (n=36) and the female subjects were 28% 
(n=14). Hence, in total, the male subjects were numerically higher than the 
female subjects in our study i.e the male subjects was admitted with higher 
frequency of snake bite  than the female subjects in our study. This is 
represented in Figure2. 
 
Table 2: Gender distribution of subjects in the study. (n=50) 
 
S.No Parameter 
Cases (n=25) Controls (n=25) 
n % n % 
1 Male 19 76 17 68 
2 Female 6 24 8 32 
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Figure 2: 
Proportion 
of gender 
distribution 
in the study 
(overall) 
n=50 
 
54 
 
6.3. TYPE OF SNAKES IN THE STUDY  
In our study of 50 subjects, the unknown snake bite accounts for 24 % 
(n=12.) Amongst the known snake bite, the snake bite by Russell’s Viper was 
the one with highest frequency (n=18, 36%).  
This is followed by common krait snake bite (n=9, 18%) and Saw scaled 
Viper bite poisoning (n=7, 14%). In our study, the cobra bite was the one with 
least frequency of 8% (n=4). 
This data are represented in table 3 and in figure 3. 
 
Table 3: Frequency distribution of type of snake in the study population. 
 
S.No Type of snakes Number (n) 
Percentage 
(%) 
1 Unknown 12 24 
2 Russell’s viper 18 36 
3 Krait 9 18 
4 Saw scaled Viper  7 14 
5 Cobra 4 8 
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Figure 3: 
Frequency 
distribution 
of type of 
snake bite 
poisoning 
in the study 
population 
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6.4 OUTCOME OF THE PATIENTS IN THE STUDY SUBJECTS 
The outcome of the patients in both control and case group of our study after 
snake bite is summarized in table 4. Out of 25 subjects in the control group, 
84% (n=21) of patients were managed conservatively. The remaining 16% 
(n=4) of subjects in the control group underwent for dialysis
(31)
. In the 16% of 
subjects who underwent dialysis, 12% (n=3) underwent hemodialysis and 4% 
(n=1) has undergone for peritoneal dialysis. 
In case group with the sample of 25 subjects, 12% (n=3) were expired during 
the study period. In the remaining patients, 32% (n=8) were managed 
conservatively and 56% (n=14) were needed dialysis. In the patients who 
underwent dialysis in cases group, numerically hemodialysis (n=9, 36%) is 
higher than the patients who underwent peritoneal dialysis (n=5, 20%). 
The outcome of the patients in snake bite without considering the group is 
presented in figure 4. In a sample of 50 subjects, overall, majority of patients 
were managed by conservative treatment (n=29, 58%). The mortality is 6% 
(n=3) and all the patients who died belong to the case group. No mortality was 
observed in the control group. On a whole, the proportions of patients who 
underwent hemodialysis (n=12, 24%) is numerically higher than the patients 
who underwent peritoneal dialysis (n=6, 12%). 
 
 
 
 
 
 
57 
 
Table 4: Type of outcome (Management) given to the patients in the study 
population with snake bites in cases and controls groups. 
S.No 
Type of Management 
undergone by the patients 
Cases 
(n=25) 
Controls 
(n=25) 
N % n % 
1 Hemodialysis 9 36 3 12 
2 Peritoneal dialysis 5 20 1 4 
3 Conservative Management 8 32 21 84 
4 Expired 3 12 0 0 
Data are expressed as absolute numbers with percentage. Total n=50 i.e 
25/group. 
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Figure 4: 
Frequency 
distribution 
of outcome 
(manageme
nt) given to 
patients in 
the study 
(overall) 
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6.5 CLINICAL SIGNS OF SNAKE BITES IN THE STUDY SUBJECTS. 
The major clinical signs such as cellulitis development and bleeding tendencies 
were assessed and reported in the table 5.  
In the control group of 25 subjects, the proportions of patients who developed 
cellulitis is 64 % (n=16) and who did not develop cellulitis was 36% (n=9).  In 
case group, 84% (n=21) has developed cellulitis and only 16% has no cellulitis. 
Hence, the proportion of patients who developed cellulitis in the snake bite is 
higher than those who did not develop in both the case and control groups. 
When these proportions are compared between the case and control groups by 
using Fisher’s Exact test, the p value obtained was 0.19 (Not significant). 
Hence, there is no statistical significant difference between the case and control 
group when the proportions of development and not-development of cellulitis 
were considered. 
Similarly, in control group with a sample of 25 subjects, 40% (n=10) of the 
patients developed bleeding manifestation after snake bite and 60% (n=15) of 
subjects did not develop bleeding manifestations. When the proportions of 
bleeding manifestations in case group of 25 subjects were considered, it has 
been observed that the 44% (n=11) developed bleeding manifestations and 56% 
(n=14) did not develop bleeding manifestation.  
When these proportions are compared between the case and control groups by 
using Fisher’s Exact test, the p value obtained was 0.99 (Not significant).  
Hence, there is no statistical significant difference between the case and control 
group when the proportions of development and not-development of bleeding 
tendencies were considered. The results are summarize in table 5. 
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Table 5: Comparison of proportions of cellulitis  and clinical bleeding 
development between cases and controls in the snake bite. 
Data are expressed as absolute numbers with percentage. 
 
 
 
 
 
 
 
 
 
 
 
 
 
S.No Parameter 
Cases 
(n=25) 
Controls 
(n=25) 
P 
Value 
n % N % 
1 Cellulitis 
Present 21 84 16 64 0.19 
(NS) Absent 4 16 9 36 
2 
Clinical 
Bleeding 
Present 11 44 10 40 0.99 
(NS) Absent 14 56 15 60 
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6.6 EFFECT OF SNAKE BITE IN THE BIOCHEMICAL PARAMETERS 
IN THE STUDY. 
The biochemical parameters such as Blood urea (mg/dl), Serum creatinine 
(mg/dl), Platelet count
(3)
 (lakhs/cc) and urine albuminuria
(22)
 were analyzed 
between the case and control groups. The results are expressed in table 6 and 
table 7. 
In controls with the sample of 25 subjects, the mean blood urea was 29.4 mg/dl 
with the standard deviation of 5.61 mg/dl. In cases group with the sample of 25 
subjects, the mean blood urea was 77.8 mg/dl with the standard deviation of 
10.8 mg/dl. Hence, the mean blood urea value of case groups is numerically 
higher than the mean blood urea value of control group (77.8 mg/dl Vs 29.4 
mg/dl).  
 
To obtain the statistically significant difference between the means, unpaired ‘t’ 
test was used to test the null hypothesis (77.8 ± 10.8 Vs 29.4 ± 5.61). The p 
value obtained was <0.0001 which is considered extremely significant. Hence, 
the mean blood urea values in the case groups are statistically higher than the 
mean blood urea value of control groups. 
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Table 6: Comparison of different biochemical parameters between cases and 
controls 
 
S.No Biochemical parameters 
Cases 
(n=25) 
Controls 
(n=25) P Value 
Mean SD Mean SD 
1 Blood Urea (Mg/dl) 77.8 10.8 29.4 5.61 <0.0001* 
2 Serum Creatinine (mg/dl) 2.8 1.03 0.86 0.14 <0.0001* 
3 Platelet count (Lakhs/cc) 1.12 0.38 1.7 0.37 <0.0001* 
 
Data are expressed as mean with standard deviation. Unpaired ‘t’ test was used 
to test the level of significance. * indicates p<0.05 and considered statistically 
significant. 
 
Similarly in controls with the sample of 25 subjects, the mean serum creatinine 
was 0.86 mg/dl with the standard deviation of 0.14 mg/dl. In cases group with 
the sample of 25 subjects, the mean serum creatinine was 2.8 mg/dl with the 
standard deviation of 1.03 mg/dl. Hence, the mean serum creatinine value of 
case groups is numerically higher than the mean serum creatinine value of 
control group (2.8 mg/dl Vs 0.86 mg/dl).  
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To obtain the statistically significant difference between the means, unpaired ‘t’ 
test was used to test the null hypothesis (2.8 ± 1.03 Vs 0.86 ± 0.14). The p value 
obtained was <0.0001 which is considered extremely significant. Hence, the 
mean serum creatinine values in the case groups are statistically higher than the 
mean serum creatinine value of control groups. 
In the same way, the platelet count between the groups was compared. In 
controls with the sample of 25 subjects, the mean platelet count was 1.7 
Lakhs/cc with the standard deviation of 0.37 Lakhs/cc. In cases group with the 
sample of 25 subjects, the mean platelet count was 1.12 Lakhs/cc with the 
standard deviation of 0.38 Lakhs/cc. Hence, the mean platelet count value of 
case groups is numerically lower than the mean platelet count value of control 
group (1.12 mg/dl Vs 1.7 mg/dl).  
To obtain the statistically significant difference between the means, unpaired ‘t’ 
test was used to test the null hypothesis (1.12 ±  0.38 Vs 1.7 ± 0.37). The p 
value obtained was <0.0001 which is considered extremely significant. Hence, 
the mean platelet count values in the case groups are statistically lower than the 
mean platelet count value of control groups. 
The frequency distribution of urine albuminuria between cases and control 
groups are summarized in table 7. The four categories of albuminuria are Nil, 
Trace, 1 plus and 2 plus.  
In control group with the 25 subjects, the highest frequency was observed in the 
‘trace category’ (n=10, 40%), followed by Nil urine albumin category (n=9, 
36%) and the 1 plus urine albumin category (n=6, 24%). No patients had urine 
albumin 2+ category in the control group. 
In case group with the 25 subjects, the highest frequency was observed in the ‘ 
urine albumin plus 2 category’ (n=10, 40%), followed by urine albumin 1plus 
category (n=8, 32%) and the urine albumin trace category (n=6, 24%). Only one 
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patient was under urine albumin nil category in the control group. Hence, on a 
whole, the proportion of the urine albuminuria is numerically higher in the case 
group than the control group patients. 
 
 
 
Table 7: Comparison of frequency distribution of urine albuminuria between 
case and control groups 
 
S.No Type of urine albuminuria 
Cases 
(n=25) 
Controls 
(n=25) 
n % n % 
1 Nil 1 4 9 36 
2 Trace 6 24 10 40 
3 1 plus 8 32 6 24 
4 2 plus 10 40 0 0 
Data are expressed as absolute numbers with percentages. 
 
6.7. EFFECTS OF SNAKE BITE ON ALBUMINURIA AND AS AN 
EARLY PREDICTOR  OF ACUTE KIDNEY INJURY. 
 
In both cases and control groups of our study, for the purpose of description, the 
urine albumin Nil and Trace category were clubbed together as “Albuminuria 
Absent’.  The remaining groups, albumin 1 Plus and albumin 2 plus were 
clubbed together as ‘Albuminuria Present’ group. 
 
In the control group of 25 subjects, the proportion of patients who has 
albuminuria was 24% (n=6) and who did not have albuminuria was 76% 
65 
 
(n=19). The proportion of the patients with albuminuria present is numerically 
lower than the proportion of patients with albuminuria absent. 
 
In case group of 25 subjects, the proportions of patients who has albuminuria 
was 72% (n=18) and who did not have albuminuria was 28% (n=7). The 
proportion of the patients with albuminuria present is numerically higher than 
the proportion of patients with albuminuria absent. 
 
To test the statistical difference between these proportions, Fisher’s Exact test 
was used and the p value obtained was 0.0015 (statistically significant). The 
relative risk obtained is 2.78 with 95% confidence interval of 1.41 to 5.4. The 
data are summarized in the table 8. 
 
 
Table 8: Comparison between the cases and controls in regards to the 
development of albuminuria . 
 
S.No Parameter 
Cases  
(n=25) 
Controls 
 (n=25) P Value 
Relative 
risk 
(95% CI) n % n % 
1 Albuminuria 
Present 18 72 6 24 
0.0015* 
2.78 
(1.41 to 
5.4) Absent 7 28 19 76 
The frequencies of albuminuria – NIL and traces are clubbed together for 
albuminuria absent group and 1+ & 2+ are combined for albuminuria present 
category. Fisher’s Exact test was used to test the level of significance. 
 
6.8. EFFECTS OF SNAKE BITE ON PLATELET COUNT AND AS AN 
EARLY PREDICTOR  OF ACUTE KIDNEY INJURY. 
 
In both cases and control groups of our study, for the purpose of description, the 
patients with platelet count less than 1.5 lakhs/cc was taken as 
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‘Thrombocytopenia Present’ and the patients with platelet count above 1.5 
lakhs/cc was taken as ‘Thrombocytopenia22 absent’ group. 
 
In the control group of 25 subjects, the proportion of patients who has 
thrombocytopenia was 28% (n=7) and who did not have thrombocytopenia was 
72% (n=18). The proportion of the patients with thrombocytopenia present is 
numerically lower than the proportion of patients with thrombocytopenia absent 
(28% Vs 72%). 
 
In case group of 25 subjects, the proportions of patients who has 
thrombocytopenia was 76% (n=19) and who did not have thrombocytopenia 
was 24% (n=6). The proportion of the patients with thrombocytopenia present is 
numerically higher than the proportion of patients with thrombocytopenia 
absent. 
 
To test the statistical difference between these proportions, Fisher’s Exact test 
was used and the p value obtained was 0.0016 (statistically significant). The 
relative risk obtained is 2.92 with 95% confidence interval of 1.4 to 6. The data 
are summarized in the table 9. 
 
 
 
Table 9:  Comparison between the cases and controls in regards to the 
thrombocytopenia. 
 
 
S. 
No 
Parameter 
Cases  
(n=25) 
Controls 
 (n=25) P Value 
Relative 
risk 
(95% CI) n % n % 
1 Thrombocytopenia 
Present 19 76 7 28 
0.0016* 
2.92 
(1.4 to 6) Absent 6 24 18 72 
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7. DISCUSSION: 
Our study aimed to determine the early prediction of acute kidney injury in the 
patients with snake bite by urine albuminuria and thrombocytopenia. The 
control groups are the patients with normal renal parameters after snake bite and 
the cases were the patients with elevated renal parameters after the snake bite. 
In our study, it was found that 
1. The mean platelet count was significantly lower in the patients with 
elevated renal parameters than the patients with normal renal 
parameters after the snake bite. 
2. The proportions of patients with albuminuria are higher in the case 
groups than the control groups. 
3. The proportions of patients with thrombocytopenia are higher in the 
case groups than the control group. 
4. The age of the patients in both the groups are equally distributed 
between the case and control groups. 
5. The gender proportion in both the case and control groups are equally 
distributed 
6. Mortality due to snake bite is 6% 
7. The common type of snake bite happened is Russell’s Viper 
8. Majority of the patients who developed acute kidney injury were 
treated with conservative management. 
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9. Clinical presentation like cellulitis and bleeding tendencies are equally 
distributed in both the groups. 
The age group of the patients with snake bite in our study with highest 
frequency is between 41 to 50 years and mean age in both case and controls 
were 41.9 and 41.5 years with no significant differences.  
Others studies conducted by Chugh KS
(62
 et al ,  Pinho F M
(63)
 et al ,  
Naqvi R  
(64)
et al  and Mukhopadhyay P
(65)
 et al  found that the mean age in 
snake bite poisoning is varying from 24 years to 43 years. Our study also has 
the mean age of patients with snake bite fall under the similar category to other 
studies. 
In both case and control groups, the males have the higher frequencies of 
snake bite poisoning than the female. This could be due to the fact that, being a 
male gender, the probability of going to work outside the home is higher than 
the female and hence the chances of accidental bite from the snake is higher in 
both the groups than the females.  
 
Other studies conducted by Pinho F M
(63)
  et al , Naqvi R
(64)
 et al , 
Mukhopadhyay P
(65)
  et al , Athappan G
(66)
 et al  and Krishnamurthy S
(67)
 et al  
found out the similar inference that the snake bite is higher in males than the 
females. The ratio of male to female in snake bite ranges from 4:1 in study 
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conducted by Ahuja 
(69)
and Singh
 
 et al to 7:3 in study conducted by Bhat 
(69)
 et 
al. Our study is also in concordance with the other studies in this aspect.  
Moreover, in our study both the age and gender were equally distributed 
between the groups. This rules out the baseline differences between the groups 
which can significantly affect the outcome, in our study the outcome being the 
development of acute kidney injury. It is well known fact that the renal function 
will be decreased with increasing age and hence age difference between the 
groups can make the interpretation of statistical differences between the group 
questionable. However, in our study, both the age and gender were equally 
distributed between the groups. 
The most common type of snake bite seen in our study is due to Russell’s 
viper. Russell’s viper along with common krait, cobra and saw scaled Viper 
constitutes the major four Snakes which are responsible for almost all of the 
snake bites in India. This is in concordance with the study conducted by Warell 
DA et al  ,Swaroop S et al , N. Suchitra 
(70)
et al and G. Ali et al. 
The mortality rate observed in our study due to snake bite poisoning was 
6%. The mortality due to snake bite poisoning in India is around 40,000 cases 
per year in 1963 which has come down to less than 2000 per year in 2010 as 
indicated by Shubhanker M
(72)
 et al . This fact is mainly due to the easy and 
frequent availability of anti snake venom in the various tertiary care hospitals.  
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Similar studies which aimed to estimate the mortality rate due to snake 
bite poisoning in India such as Viramani 
(73)
SK et al , Bawaskar HS 
(74)
et al , 
Brunda G
(75)
 et al  and Majumder D
(76)
 et al  reported that the mortality rate as 
higher values ranging from 40% to 80%. However in our study we observed 
only 6% mortality rate. This could be due to two facts.  
First of all, our study was conducted in a tertiary care hospital which has 
surplus access to the anti-snake venom and the complications developed were 
managed effectively with life support care. Second, on retrospective analysis, it 
was found that majority of the cases included in the study was residing within 
50 kilometers radius from the hospital. Hence with advance treatment and easy 
access to the hospital could make the mortality rate low in our study similar to 
Kalantri S
(77)
 et al and Kulkarni 
(78)
et al
 
 study (mortality 2.6 and 5.2% 
respectively). 
Acute kidney injury is the most dreaded complication which can develop 
in the snake bite, especially with hemotoxic snake bite like Viper bites. In our 
study conducted in 50 subjects with acute kidney injury due to snake bite, the 
majority of the patients were managed conservatively (58%) and 36% required 
dialysis. 
 The proportion of patients underwent dialysis is higher in the case groups 
than the control groups (56% Vs 16%). Studies conducted by Pinho F M
(63)
 et al  
, Athappan G 
(66)
et al 
,
 and Kalana M et al  have reported that the Acute Kidney 
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injury is the one of the common complications which can develop in the 
hemotoxic snake bite. In our study, the commonest snake bite poisoning noted 
was Russell’s Viper. Hence the higher proportions of hemodialysis required in 
our study could be partly explained by the type of snake poisoning: Russell’s 
Viper in our case.  
Cellulitis and bleeding tendencies are the more common complication 
observed in the snake bite besides Acute Kidney Injury. In the study conducted 
by Athappan G
(66)
 et al  the cellulitis was observed in higher frequencies. In our 
study, overall (50 subjects), 74% subjects developed cellulitis while 26% patient 
did not develop cellulitis. This proportion is similar to study conducted by 
Athappan G
(66)
 et al. 
Similarly, in the studies conducted by N. Suchitra
(70)
 et al and G. Ali et al 
the bleeding tendencies observed was significantly associated with the 
development of Acute kidney injury. In our study, overall, 42% developed 
clinical bleeding while 58% did not develop the clinical bleeding 
manifestations. This proportion is slightly higher than the frequency observed in 
study conducted by Athappan G
(66)
 et al (22.7%). However, the bleeding 
tendencies noted in our study is comparable with study conducted by N. 
Suchitra 
(70)
et al and G. Ali et al. These varying results in proportion of bleeding 
tendencies noted in the study can be relatively explained by the fact that the 
bleeding tendency depends on many factors. Factors like type of snake 
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envenomation, amount of toxin injected and presence of other co-morbidity 
contributes in large.  
The mean platelet count observed in the control group (patients with 
normal renal parameters in snake bite poisoning) was 1.7 lakhs/cc with the 
standard  deviation of 0.37. However, the mean platelet count noted in the case 
group (patients who developed elevated renal parameters after snake bite) was 
1.12 lakhs/cc with standard deviation of 0.38. This indicates that the mean 
platelet count in the case group falls under thrombocytopenia category. 
Moreover we also found the statistical significant difference between mean 
platelet count between the cases and controls (1.7±0.37 in control Vs 1.12 ± 
0.38 in case). The patients with elevated renal parameters after snake bite  
developed thrombocytopenia and their platelet count was significantly lower 
than the patients with normal renal parameters. 
Severe blood loss can be caused by the bleeding tendencies in the snake 
bite. Pinho F M
(63)
 et al , Athappan G
(66)
 et al  N. Suchitra
(70)
 et al, G. Ali et al
 
and Sharma et al  have found that the bleeding tendencies in the snake bite as 
the good associative factor in occurrence of Acute Kidney injury. Our study is 
also in concordance with these facts. 
In our study, when the proportion of development of thrombocytopenia 
was compared with those who did not develop in case and control group, the 
relative risk obtained was 2.92 (95% confidence interval of 1.4 to 6; p value of 
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0.00016). Hence it could be noted that the patients who developed 
thrombocytopenia
 
after snake bite will have 2.92 times higher risk of having 
acute kidney injury.  
Many predictors of acute kidney injury like bite to hospital time, low 
systolic blood pressure on presentation, bleeding time and albuminuria were 
reported in various studies. Paul 
(81)
et al  has found that hematuria and 
albuminuria was associated with development of acute kidney injury.  
In our study, in case groups, 72% developed albuminuria and only 24% 
developed  albuminuria  in control groups. When the proportions are compared 
between the groups, we found significant higher proportion of albuminuria in 
case groups. The relative risk obtained was 2.78 (95% confidence interval of 
1.41 to 5.4). Hence, the risk of developing acute kidney injury was 2.78 times 
higher in the patients with albuminuria than those without albuminuria. This 
finding was in concordance with the study conducted by Mrudul V
(82)
 et al 
. 
Hence from the above results it could be inferred that the albuminuria and 
thrombocytopenia are strongly associated with development of acute kidney 
injury.
 
The major limitations in our study was that we did not considered other 
factors that could possibly affect the development of acute kidney injury like 
time to hospital, dose of ASV administered and development of hypotension. In 
future studies, multivariate analysis considering all the possible factors affecting 
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the outcome of patients with snake bite with same study design would provide 
further information. Nevertheless our study gives a direct evidence(based on 
relative risk) that the albuminuria and thrombocytopenia in the setting of snake 
bite  could predict the need for dialysis at an early stage . 
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8. CONCLUSION: 
In patients with snake bite, 
a. Albuminuria and thrombocytopenia are associated with development 
of Acute kidney injury 
b. Presence of thrombocytopenia can predict the occurrence of Acute  
Kidney Injury at the earlier stage. 
c. Presence of albuminuria can predict the occurrence of Acute kidney 
Injury at the earlier stage. 
 
 
 
 
 
 
 
 
 
76 
 
 
9. REFERENCES 
1.Deutschman, Clifford S.; Neligan, Patrick J. (2010). Evidence-based Practice 
of Critical Care. Elsevier Health Sciences.ISBN 1416054766.Retrieved 2015-
04-30. 
2. "Platelet count: MedlinePlus Medical Encyclopedia". www.nlm.nih.gov. 
Retrieved 2015-05-01.  
3. Bhatia, M.P.S. "B.E. Project on Platlet Count Using Image Processing 
Techniques" (PDF). BTP_Report.Retrieved 30 November 2014. 
4.Houghton, Andrew R.; Gray, David (2010).Chamberlain's Symptoms and 
Signs in Clinical Medicine 13th Edition, An Introduction to Medical Diagnosis. 
CRC Press.ISBN 9780340974254.Retrieved 2015-05-01. 
5.Interpreting Signs and Symptoms. Lippincott Williams & Wilkins. 2007. 
p. 293.  
6."What Causes Thrombocytopenia?".National Heart, Lung, and Blood 
Institute.Retrieved 4 December 2014. 
7.Fiebach, Nicholas H.; Barker, Lee Randol; Burton, John Russell; Zieve, Philip 
D. (2007). Principles of Ambulatory Medicine.Lippincott Williams & 
Wilkins.ISBN 9780781762274.Retrieved 2015-04-30. 
77 
 
8.Rodak, Bernadette F.; Fritsma, George A.; Keohane, Elaine (2013). 
Hematology: Clinical Principles and Applications. Elsevier Health 
Sciences.ISBN 9780323292696.Retrieved 2015-04-30. 
9.Gresele, Paolo; Fuster, Valentin; Lopez, Jose A.; Page, Clive P.; Vermylen, 
Jos (2007). Platelets in Hematologic and Cardiovascular Disorders: A Clinical 
Handbook. Cambridge University Press.ISBN 9781139468763.Retrieved 2015-
04-30. 
10.Waldmann, Carl; Soni, Neil; Rhodes, Andrew (2008). Oxford Desk 
Reference: Critical Care. Oxford University 
Press.ISBN 9780199229581.Retrieved 2015-05-01. 
11.  Dart, Richard C. (2004). Medical Toxicology.Lippincott Williams & 
Wilkins.ISBN 9780781728454.Retrieved 2015-05-01. 
12.  Greer, John P.; Arber, Daniel A.; Glader, Bertil; List, Alan F.; Means, 
Robert T.; Paraskevas, Frixos; Rodgers, George M. (2013). Wintrobe's Clinical 
Hematology.Lippincott Williams & Wilkins.ISBN 9781469846224.Retrieved 
2015-05-01. 
13."How Is Thrombocytopenia Diagnosed? - NHLBI, NIH".www.nhlbi.nih.gov. 
Retrieved 2015-05-19. 
14.Hillyer, Christopher D.; Abrams, Charles S.; Shaz, Beth H.; Roshal, Mikhail; 
Zimring, James C.; Abshire, Thomas C. (2009). Transfusion Medicine and 
78 
 
Hemostasis: Clinical and Laboratory Aspects. 
Elsevier.ISBN 9780080922300.Retrieved 2015-05-01. 
15."How Is Thrombotic Thrombocytopenic Purpura Treated? - NHLBI, NIH". 
www.nhlbi.nih.gov. Retrieved 2015-05-20.  
16.Thrombocytopenic Purpura: New Insights for the Healthcare Professional: 
2013 Edition: ScholarlyPaper. ScholarlyEditions. 
17."Idiopathic thrombocytopenic purpura (ITP): MedlinePlus Medical 
Encyclopedia". www.nlm.nih.gov. Retrieved 2015-05-20.  
18.Warkentin, Theodore E.; Greinacher, Andreas (2007-07-23). Heparin-
Induced Thrombocytopenia.CRC Press.ISBN 9781439826423. 
19.  Ahmed, I; Majeed, A; Powell, R (2007). "Heparin induced 
thrombocytopenia: diagnosis and management update". Postgraduate Medical 
Journal. 83 (983): 575–582. ISSN 0032-5473.PMC 2600013 
.PMID 17823223.doi:10.1136/pgmj.2007.059188.  
20. KDIGO (Kidney Disease Improving Global Outcomes (2013). "KDIGO 
2012 Clinical Practice Guideline for the Evaluation and Management of 
Chronic Kidney Disease" (PDF). Kidney International Supplement. 3 (1): 1–
150. Retrieved 5 February 2016. 
21.  Page 291 in: Basic Skills in Interpreting Laboratory Data. ISBN 978-1-
58528-180-0.Retrieved 23 May 2013. 
79 
 
22.  Person—microalbumin level (measured) at Australian Institute of Health 
and Welfare. 01/03/2005  
23. KDIGO 2012. "Clinical Practice Guideline for the Evaluation and 
Management of Chronic Kidney Disease" (PDF). 
24.  Webb S, Dobb G (December 2007). "ARF, ATN or AKI? It's now acute 
kidney injury". Anaesthesia and Intensive Care. 35 (6): 843–44. 
PMID 18084974. 
25.  Dan Longo; Anthony Fauci; Dennis Kasper; Stephen Hauser; J. Jameson; 
Joseph Loscalzo (July 21, 2011). Harrison's Principles of Internal Medicine, 18 
edition. McGraw-Hill Professional. 
26.  Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, 
Levin A (2007). "Acute Kidney Injury Network: report of an initiative to 
improve outcomes in acute kidney injury". Critical Care (London, England). 11 
(2): R31. PMC 2206446  .PMID 17331245.doi:10.1186/cc5713.  
27.  Skorecki K, Green J, Brenner BM (2005). "Chronic renal failure". In 
Kasper DL, Braunwald E, Fauci AS, et al. Harrison's Principles of Internal 
Medicine (16th ed.). New York, NY: McGraw-Hill. pp. 1653–63. ISBN 0-07-
139140-1. 
80 
 
28.  Tierney, Lawrence M.; Stephen J. McPhee; Maxine A. Papadakis (2004). 
"22". CURRENT Medical Diagnosis and Treatment 2005 (44th ed.). McGraw-
Hill.p. 871.ISBN 0-07-143692-8. 
29.  Brady HR, Brenner BM (2005). "Chronic renal failure". In Kasper DL, 
Braunwald E, Fauci AS, et al. Harrison's Principles of Internal Medicine (16th 
ed.). New York, NY: McGraw-Hill. pp. 1644–53. ISBN 0-07-139140-1. 
30.  Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney 
Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney 
Injury.Kidney inter.  
31.  Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P (2004). "Acute 
renal failure - definition, outcome measures, animal models, fluid therapy and 
information technology needs: the Second International Consensus Conference 
of the Acute Dialysis Quality Initiative (ADQI) Group". Crit Care. 8 (4): R204–
12. PMC 522841  .PMID 15312219.doi:10.1186/cc2872.  
32.  Lameire N, Van Biesen W, Vanholder R (2005). "Acute renal 
failure".Lancet. 365 (9457): 417–30. PMID 15680458.doi:10.1016/S0140-
6736(05)17831-3.  
33.  Chawla LS, Kellum JA (Jan 17, 2012). "Acute kidney injury in 2011: 
Biomarkers are transforming our understanding of AKI.".Nature Reviews 
Nephrology. 8 (2): 68–70. PMID 22249777.doi:10.1038/nrneph.2011.216.  
81 
 
34.  Papadakis MA, McPhee SJ (2008). Current Medical Diagnosis and 
Treatment.McGraw-Hill Professional.ISBN 0-07-159124-9. 
35.  Palevsky PM, Zhang JH, O'Connor TZ, Chertow GM, Crowley ST, 
Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM, Smith MW, 
Swanson KM, Thompson BT, Vijayan A, Watnick S, Star RA, Peduzzi P (July 
2008). "Intensity of renal support in critically ill patients with acute kidney 
injury".The New England Journal of Medicine. 359 (1): 7–20.  
36.  Pannu N, Klarenbach S, Wiebe N, Manns B, Tonelli M (February 2008). 
"Renal replacement therapy in patients with acute renal failure: a systematic 
review". JAMA: the Journal of the American Medical Association. 299 (7): 
793–805. PMID 18285591.doi:10.1001/jama.299.7.793.  
37. Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lo S, McArthur C, 
McGuinness S, Myburgh J, Norton R, Scheinkestel C, Su S (October 2009). 
"Intensity of continuous renal-replacement therapy in critically ill patients".The 
New England Journal of Medicine. 361 (17): 1627–38.  
38.  Schoenfelder, T; Chen, X; Bless, HH (March 2017). "Effects of continuous 
and intermittent renal replacement therapies among adult patients with acute 
kidney injury". GMS Health Technol Assess. 13 (Doc01 (20170301)).Retrieved 
8 August 2017. 
82 
 
39.  Schneider, AG; Bellomo, R; Bagshaw, SM; Glassford, NJ; Lo, S; Jun, M; 
Cass, A; Gallagher, M (June 2013). "Choice of renal replacement therapy 
modality and dialysis dependence after acute kidney injury: a systematic review 
and meta-analysis.".Intensive care medicine. 39 (6): 987–97. 
PMID 23443311.doi:10.1007/s00134-013-2864-5.  
40.  Coca, SG; Singanamala, S; Parikh, CR (March 2012). "Chronic kidney 
disease after acute kidney injury: a systematic review and meta-
analysis.".Kidney International. 81 (5): 442–48. PMC 3788581 
.PMID 22113526.doi:10.1038/ki.2011.379.  
41.  "Renal Medicine: Acute Kidney Injury (AKI)". Renalmed.co.uk. 2012-05-
23.Archived from the original on 2013-08-08.Retrieved 2013-07-17. 
42.  Moyce, Sally, RN, BSN; Joseph, Jill, MD, PhD; Tancredi, Daniel, PhD; 
Mitchell, Diane, PhD; Schenker, Marc, MD, MPH (2016) "Cumulative 
Incidence of Acute Kidney Injury in California's Agricultural Workers" Journal 
of Environmental Medicine JOEM 58 Number 4, April 2016 391–97  
43.  Brenner and Rector's The Kidney. Philadelphia: Saunders. 2007. ISBN 1-
4160-3110-3.  
44.Siew ED, Davenport A (2015). "The growth of acute kidney injury: a rising 
tide or just closer attention to detail?".Kidney International (Review). 87 (1): 
46–61. PMC 4281297 
83 
 
45.Schrier RW, Wang W, Poole B, Mitra A (2004)."Acute renal failure: 
definitions, diagnosis, pathogenesis, and therapy". J. Clin. Invest.2000114: 5–
14. 
46.  (Bauchot, Roland (1994). Snakes: A Natural History. New York City, NY, 
USA: Sterling Publishing Co., Inc. pp. 194–209. ISBN 1-4027-3181-7. 
47.  (edited by) Halliday; Adler, Tim; Kraig (2002). Firefly Encyclopedia of 
Reptiles and Amphibians. Toronto, Canada: Firefly Books Ltd. pp. 202–203. 
ISBN 1-55297-613-0. 
48.Bottrall, Joshua L.; Frank Madaras; Christopher D Biven; Michael G 
Venning; Peter J Mirtschin (30 September 2010). "Proteolytic activity of Elapid 
and Viperid Snake venoms and its implication to digestion".Journal of Venom 
Research. 1 (3): 18–28.  
49.Mattison, Chris (2007 (first published in 1995)). The New Encyclopedia of 
Snakes. New Jersey, USA (first published in the UK): Princeton University 
Press (Princeton and Oxford) first published in Blandford. p. 117. 
50.Condrea, E.; De Vries, A.; Mager, J. (February 1964). "Hemolysis and 
splitting of human erythrocyte phospholipids by snake 
venoms".BiochimicaetBiophysicaActa (BBA) - Specialized Section on Lipids 
and Related Subjects. 84 (1): 60–73.  
84 
 
51. Rodríguez-Ithurralde, D.; R. Silveira; L. Barbeito; F. Dajas (1983). 
"Fasciculin, a powerful anticholinesterase polypeptide from 
Dendroaspisangusticeps venom".Neurochemistry International. 5 (3): 267–274.  
52.  Hodgson, Wayne C.; Wickramaratna, Janith C. (September 2002). "In vitro 
neuromuscular activity of snake venoms" (PDF).Clinical and Experimental 
Pharmacology and Physiology. 29 (9): 807–814. 
53.  He, Ying-Ying; Lee, Wei-Hui; Zhang, Yun (September 2004). "Cloning 
and purification of α-neurotoxins from king cobra 
(Ophiophagushannah)".Toxicon. 44 (3): 295–303.  
54.Bernardoni, Juliana L.; Sousa, Leijiane F.; Wermelinger, Luciana S.; Lopes, 
Aline S.; Prezoto, Benedito C.; Serrano, Solange M. T.; Zingali, Russolina B.; 
Moura-da-Silva, Ana M. (2014-10-14). "Functional Variability of Snake Venom 
Metalloproteinases: Adaptive Advantages in Targeting Different Prey and 
Implications for Human Envenomation". PLOS ONE. 9 (10): e109651.  
55.  Broad, AJ; Sutherland, SK; Coulter, AR (17 May 1979). "The Lethality in 
mice of dangerous Australian and other snake venoms" (PDF).Toxicon.2013, 17 
(6): 661–664.  
56.  Fry, B.G.; Casewell, N.R.; Wuster, W.; Vidal, N.; Jackson, T. N. W.; 
Young, B. (2012). "The structural and functional diversification of the 
Toxicofera reptile venom system".Toxicon. 60 (4): 434–448. PMID 22446061. 
85 
 
57.Casewell, N.R.; Wuster, W.; Vonk, F.J.; Harrison, R.A.; Fry, B.G. (2013). 
"Complex cocktails: the evolutionary novelty of venoms". Trends in Ecology & 
Evolution. 28 (4): 219–229. 2012. 
58.Lomonte, B.; Fernandez, J.; Sanz, L.; Angulo, Y.; Sasa, M.; Gutierrez, J. M.; 
Calvete, J. J. (2014). "Venomous snakes of Costa Rica: Biological and medical 
implications of their venom proteomic profiles analyzed through the strategy of 
snake venomics". Journal of Proteomics. 105: 323–339.  
59.  Lynch, Vincent J. (January 2007). "Inventing an arsenal: Adaptive 
evolution and neofunctionalization of snake venom phospholipase A2 
genes".BMC Evolutionary Biology. 7 (2): 2. PMC 1783844 
.PMID 17233905.doi:10.1186/1471-2148-7-2.  
60.Pahari, S.; Bickford, D.; Fry, B. G.; Kini, R. M. (2007). "Expression pattern 
of three-finger toxin and phospholipase A2 genes in the venom glands of two 
sea snakes, Lapemiscurtus and Acalyptophisperonii: Comparison of evolution 
of these toxins in land snakes, sea kraits and sea snakes". BMC Evolutionary 
Biology.7: 175.PMC 2174459  .PMID 17900344.doi:10.1186/1471-2148-7-
175.  
61.  Barlow, A.; Pook, C. E.; Harrison, R. A.; Wuster, W. (July 2009). 
"Coevolution of diet and prey-specific venom activity supports the role of 
selection in snake venom evolution". Proceedings of the Royal Society B: 
86 
 
Biological Sciences. 276 (1666): 2443–9. JSTOR 30244073.PMC 2690460 
.PMID 19364745.doi:10.1098/rspb.2009.0048.  
62.K. S. Chugh, B. K. Aikat, B. K. Sharma et al.  Acute Renal Failure 
Following Snakebite. Am. J. Trop. Med. Hyg., 24(4), 1975, pp. 692-697. 
63.Pinho FM1, Yu L, Burdmann EA. Snakebite-induced acute kidney injury in 
Latin America.SeminNephrol. 28 (4), 2008, pp. 354-362. 
64.Naqvi R. Snake-bite-induced Acute Kidney Injury.J Coll Physicians Surg 
Pak. 26 (6), 2016, pp. 517-520. 
65.P. Mukhopadhyay, R. Mishra, D. Mukherjee et al. Snakebite mediated acute 
kidney injury, prognostic predictors, oxidative and carbonyl stress: A 
prospective study. Indian J Nephrol. 26 (6), 2016, pp, 427–433. 
66.Ganesh Athappan et al. Acute Renal Failure in Snake Envenomation: A  
large Prospective Study. Saudi J KidneyDisTranspl 19(3), 2008, pp 404- 410. 
67.Krishnamurthy S, Narayanan P, Prabha S et al. Clinical profile of acute 
kidney injury in a pediatric intensive care unit from Southern India: A 
prospective observational study. Indian J Crit Care Med. 17 (4), 2013, pp. 207-
213. 
68.Ahuja MM. Progress in clinical medicine in India. Second Series. 1978:136–
77. 
87 
 
69.Bhat RN. Viperine snake poisoning in Jammu. J Indian Med Assoc. 1974, 
63, pp. 383–92. 
70.Suchitra N. et al Snake bite Envenoming in Kerala, South India: Clinical 
profile and factors involved in adverse outcomes. EMJ 25, 2008, pp. 200-204. 
71.Ali G., Kak M. et al. Acute Renal Failure following EchisCarinatus 
envenomation. Indian J Nephrol 14, 2004, pp. 177-181. 
72.ShubhankerMitra, AbhinavAgarwal, B. U. Shubhankar et al. Clinico-
epidemiological Profile of Snake Bites over 6-year Period from a Rural 
Secondary Care Centre of Northern India: A Descriptive Study. Toxicol Int. 
22(1), 2015, pp. 77–82. 
73.Viramani SK, Dutt O.P. A profile of snake bite poisoning in Jammu region. J 
Indian Med Assoc. 85, 1987, pp. 132–34. 
74.Bawaskar HS, Bawaskar PH, Punde DP, Inamdar MK, Dongare RB, Bhoite 
RR J Assoc Physicians India. 2008 Feb; 56: pp. 88-95. 
75.Brunda G, Sashidhar RB. Epidemiological profile of snake-bite cases from 
Andhra Pradesh using immunoanalytical approach. Indian J Med Res. 125, 
2007, pp. 661–668. 
76.Majumder D, Sinha A, Bhattacharya SK, Ram R, Dasgupta U, Ram A. 
Epidemiological profile of snake bite in south 24 Parganas district of West 
88 
 
Bengal with focus on underreporting of snake bite deaths. Indian J Public 
Health. 58, 2014,pp 17–21. 
77.Kalantri S, Singh A, Joshi R, Malamba S, Ho C, Ezoua J, et al. Clinical 
predictors of in-hospital mortality in patients with snake bite: A retrospective 
study from a rural hospital in central India. Trop Med Int Health. 11, 2006, pp 
22–30. 
78.Kulkarni M. Ances. Snake venom Poisons, experience with 633 pt.-Indian 
Paed. 31, 1994, pp. 1239-43. 
79.KalanaMaduwage and Geoffrey K. Isbister. Current Treatment for Venom-
Induced Consumption Coagulopathy Resulting from Snakebite. PLoSNegl Trop 
Dis. 8(10), 2010, pp. e3220 
80.Sharma N, Chauhan S, Faruqi S, Bhat P, Varma S. Snake envenomation in a 
north Indian hospital. Emerg Med J. 22, 2005, pp.118–20. 
81Paul J, Dasgupta S.Early Prediction of acute kidney injury by clinical features 
of snakebite patients at the time of hospital admission. N Am J Med Sci. 4, 
2012, pp. 216–20. 
82.Mrudul V Dharod, Tushar B Patil, Archana S Deshpande et al. Clinical 
Predictors of Acute Kidney Injury Following Snake Bite Envenomation. N Am 
J Med Sci. 5(10), 2013, pp. 594–599. 
 
89 
 
PROFORMA 
“A STUDY ON THROMBOCYTOPENIA AND ALBUMINURIA AS EARLY 
PREDICTORS OF AKI IN SNAKE BITE” 
PARTICULARS OF THE PARTICIPANT : 
Name:                                                 Age:              Sex: M/F    Diet: V/NV 
Address:                                                             Occupation: 
PRESENTING COMPLAINT: 
H/O SNAKE BITE                               YES/NO 
DURATION BETWEEN BITE TIME AND HOSPITAL ADMISSION:  
NATURE OF SNAKE:  
SPECIFIC COMPLAINT: 
PAST  HISTORY : 
□ DM                                              □ HT                          □ Renal disorders                          
 
GENERAL  EXAMINATION : 
 
Blood Pressure: 
Pulse Rate:                                                                              
Pedal edema: 
 
SYSTEMIC  EXAMINATION : 
 
CVS :     R/S : 
 
ABDOMEN :    CNS : 
 
INVESTIGATIONS : 
 
BloodUrea :              Serum Creatinine :   
 
 
Urine -   Albumin :   Platelet Count: 
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CONSENT FORM 
 
I __________________________________________  hereby give consent to participate in 
the study conducted by DR .J.SUDHAKARAN , Post graduate in the Department of  General Medicine 
,Thanjavur Medical College & Hospital, Thanjavur – 613004 and to use my personal clinical data and 
result of investigation for the purpose of analysis and to study the nature of disease. I also give 
consent for further investigations 
 
 
Place : 
Date :       Signature of participant 
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INFORMATION SHEET 
We are conducting a Observational study on “A STUDY ON 
THROMBOCYTOPENIA AND ALBUMINURIA AS EARLY PREDICTORS 
OF AKI IN SNAKE BITE” (MARCH 2017 -AUGUST 2017)in the Dept. of 
Internal Medicine and IMCU, Thanjavur  Medical College & 
Hospital,Thanjavur – 613004. 
 
 At the time of announcing the results and suggestions, name and 
identity of the patients will be confidential. 
 
 Taking part in this study is voluntary. You are free to decide whether to 
participate in this study or to withdraw at any time; your decision will 
not result in any loss of benefits to which you are otherwise entitled. 
 
 The results of the special study may be intimated to you at the end of 
the study period or during the study if anything is found abnormal which 
may aid in the management or treatment.  
 
 
 
 
 
 
 
Signature of investigator  Signature of participant 
Date: 
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Master Chart Page 1 
 
S. 
No 
name Age sex 
blood 
urea 
g/dl1 
sr 
creatinine 
mg/dl  
Platelet 
count (in 
lakhs/cc)  
urine 
albu
min  
Presence 
of clinical 
bleeding 
Type of snake 
Presence 
of 
cellulitis 
Dialysis 
type/ 
outcome 
GROUP 
1 murugan 33 M 26 0.85 1.25 1+ NO RUSSELS VIPER YES CONS CONTROL 
2 govinda raj 55 M 34 0.6 2.2 trace YES KRAIT NO CONS CONTROL 
3 muthu 38 M 39 1.1 2 nil NO RUSSELS VIPER YES CONS CONTROL 
4 jayaraman 50 M 29 1.0 2.46 1+ NO SAWSCALED VIPER YES CONS CONTROL 
5 jayaraman 55 M 33 0.75 0.9 nil YES UNKNOWN NO CONS CONTROL 
6 neelavathy 35 F 36 0.8 1.5 trace NO SAWSCALED VIPER YES CONS CONTROL 
7 anthonysamy 60 M 27 0.9 1.8 trace YES UNKNOWN NO CONS CONTROL 
8 kaliyarajan 30 M 92 4.0 1.89 nil NO RUSSELS VIPER YES HD CONTROL 
9 muniyan 55 M 36 0.8 1.24 nil NO UNKNOWN YES CONS CONTROL 
10 prashanth 24 M 31 0.7 2.02 1+ YES SAWSCALED VIPER YES CONS CONTROL 
11 shanmugam 45 M 27 0.6 1.17 trace YES COBRA YES CONS CONTROL 
12 suguna 31 F 23 0.8 1.8 1+ YES UNKNOWN YES CONS CONTROL 
13 kamaraj 40 M 58 2.8 1.67 trace NO RUSSELS VIPER YES PD CONTROL 
14 gopi 35 M 35 0.9 1.8 nil NO RUSSELS VIPER YES CONS CONTROL 
15 govindha samy 55 M 34 0.9 2 trace NO KRAIT YES CONS CONTROL 
16 muniyamal 30 F 26 1.0 1.28 1+ NO RUSSELS VIPER YES CONS CONTROL 
17 lalitha 35 F 82 5.6 1.89 nil NO UNKNOWN NO HD CONTROL 
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Master Chart Page 2 
S. 
No 
name age sex 
blood 
urea 
g/dl1 
sr creatinine 
mg/dl  
Platelet count 
(in lakhs/cc)  
urine 
albu
min  
Presence of 
clinical 
bleeding 
Type of snake 
Presence 
of 
cellulitis 
Dialysis 
type/outco
me 
GROUP 
18 kanagavalli 21 F 26 0.6 2.1 nil NO SAWSCALED VIPER NO CONS CONTROL 
19 raja 45 M 33 0.8 1.91 nil YES UNKNOWN NO CONS CONTROL 
20 chellammal 55 F 37 0.8 1.14 trace NO KRAIT NO CONS CONTROL 
21 jayam 55 F 33 0.9 1.47 trace NO RUSSELS VIPER YES CONS CONTROL 
22 shanmugam 30 M 96 6.8 1.7 trace NO RUSSELS VIPER YES HD CONTROL 
23 rajesh 28 M 26 0.9 1.9 1+ YES KRAIT NO CONS CONTROL 
24 subbaiya 60 M 27 0.9 1.72 nil YES SAWSCALED VIPER NO CONS CONTROL 
25 jayanthi 38 F 22 0.8 1.8 trace YES UNKNOWN YES CONS CONTROL 
26 natarajan 46 M 60 1.6 1.3 nil NO KRAIT YES CONS CASES 
27 padmini 50 F 62 1.4 0.67 trace NO RUSSELS VIPER YES CONS CASES 
28 mahendran 44 M 56 4.2 1.8 trace NO COBRA YES EXPIRED CASES 
29 mohan 50 M 79 3.7 1.2 1+ NO UNKNOWN YES CONS CASES 
30 vijaya kumari 44 F 60 3.1 0.75 1+ YES KRAIT YES PD CASES 
31 selvarani 56 F 80 4.6 1.04 1+ YES SAWSCALED VIPER YES HD CASES 
32 chinnappa 54 M 72 6.8 0.76 2+ YES RUSSELS VIPER YES HD CASES 
33 solomon 40 M 85 2.6 1.7 trace YES RUSSELS VIPER NO PD CASES 
34 selvi 45 F 54 3.6 1.11 2+ YES UNKNOWN YES CONS CASES 
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Master Chart Page 3 
S. 
No 
name age sex 
blood 
urea 
g/dl1 
sr 
creatinine 
mg/dl  
Platelet 
count (in 
lakhs/cc)  
urine 
albumin  
Presence 
of clinical 
bleeding 
Type of snake 
Presence 
of 
cellulitis 
Dialysis 
type/Outcome 
GROUP 
35 kandan 65 M 72 3.7 1.2 1+ NO SAWSCALED 
VIPER 
YES CONS CASES 
36 suresh 18 M 77 5.3 1.6 1+ NO KRAIT YES HD CASES 
37 bharath pavith 18 M 60 1.4 0.87 1+ NO RUSSELS VIPER NO CONS CASES 
38 pandian 42 M 79 6.7 0.96 2+ NO COBRA YES HD CASES 
39 narayana swamy 70 M 89 6 1.76 trace NO UNKNOWN YES HD CASES 
40 elancheliyan 21 M 78 3.4 0.8 2+ YES RUSSELSVIPER YES HD CASES 
41 sakthivel 17 M 80 1.4 1.7 trace NO KRAIT NO HD CASES 
42 laksmanan 12 M 58 1.8 0.96 2+ YES RUSSELS VIPER YES CONS CASES 
43 tamil selvan 46 M 78 1.9 0.67 2+ NO RUSSELS VIPER NO PD CASES 
44 gnanamary 47 F 89 4.1 0.91 2+ YES COBRA YES HD CASES 
45 paramasivam 34 M 78 3.4 0.78 2+ YES UNKNOWN YES EXPIRED CASES 
46 manavalan 68 M 90 3.6 0.73 trace NO RUSSELS VIPER YES EXPIRED CASES 
47 saroja 45 F 89 3.4 1.6 2+ YES RUSSELS VIPER YES HD CASES 
48 haji ibram shah 58 M 58 3.1 1.08 1+ YES KRAIT YES CONS CASES 
49 kumar 38 M 96 4.7 0.7 1+ NO UNKNOWN YES PD CASES 
50 Madhankumar 21 M 78 1.9 1.36 2+ NO RUSSELS VIPER YES PD CASES 
 
 
 
 
